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ABSTRACT 
Adherence to a prescribed medication regimen is often critical to successful disease 
management. Cancer diagnoses often further complicate control of the comorbid diseases. Older 
cancer patients with multiple comorbidities receiving chemotherapy treatment are at increased 
risk for adverse health outcomes from uncontrolled disease when nonadherent to their 
medication regimen. The intent of this pilot study was to test the validity of an evidence-based 
screening instrument designed to identify patients at risk for medication nonadherence and 
uncontrolled illness. The W-BMA (Washburn-Barrier to Medication Adherence) screening 
criteria were applied to retrospective data of cancer patients with multiple co-morbidities. SPSS 
was used to analyze the data using classification trees to compare the W-BMA screen with the 
current screens used in the clinic alone. The W-BMA identified a significantly larger number of 
patients with barriers than the current screens alone. Barriers found by the W-BMA screening 
instrument are strongly related to uncontrolled illness, and, these barriers are often multi-layered, 
impacting adherence and the health of the patient. Incidentally, there was strong evidence that 
patients who have barriers addressed by oncology support services (nurse navigation and social 
work) often fare much better than patients who do not. The instrument studied in this pilot 
project requires additional analysis and refinement, however, there is strong evidence that proper 
use of the W-BMA screening instrument used as part of a comprehensive medication adherence 
program may improve adherence and lower risk of uncontrolled illness and adverse events.  
 Keywords: Adherence, medication, barriers, screening, cancer, comorbidities, instrument  
  
ADDRESSING BARRIERS TO ADHERENCE  4 
Copyright 2018 
By  
Donna Jean Washburn 
 
 
  
ADDRESSING BARRIERS TO ADHERENCE  5 
Dedication 
 This work is dedicated to my family. Family is a word that has developed new meaning 
for me over the years as our family has grown to include loved ones in every sense of the word. I 
love you and owe you all thanks for your understanding and encouragement during this long 
endeavor. An extra, special thank you to my husband Loren. I love you and there are simply no 
words to adequately express my gratitude for your support throughout all my educational 
adventures.  
Philippians 1:3-6 “I thank my God upon every remembrance of you, Always in every prayer of 
mine for you all making request with joy, For your fellowship in the gospel from the first day 
until now; Being confident of this very thing, that he which hath begun a good work in you will 
perform it until the day of Jesus Christ…” 
 
 
 
 
 
 
 
 
 
ADDRESSING BARRIERS TO ADHERENCE  6 
Acknowledgments 
 “Behold, I will do a new thing; now it shall spring forth; shall ye not know it? I will even 
make a way in the wilderness, and rivers in the desert.” Isaiah 43:19  
First, I must acknowledge the Lord and His merciful, gracious hand in my life. Much has 
transpired since beginning this program and sometimes the goal was very distant and dimly lit. 
Yet He kept the path clear and provided for every need as I journeyed on. I would like to express 
my gratitude to the Doctor of Nursing faculty, Project Chair, and Staff of Liberty University, as 
well as my DNP mentors in the practicum settings for sharing their invaluable knowledge and 
experience along with prayer, help, and encouragement during this journey. What a privilege and 
blessing it has been to learn from you all. My grateful thanks are also extended to the 
administration, physicians, nurses, and staff of Centra’s Alan B. Pearson Cancer Center for the 
extra support that was pivotal to the conduct of this research. Your genuine concern for, and 
dedication to, each of your patients touches my heart and I hope that this research will in some 
way help you as you constantly look for ways to improve the already meticulous, compassionate 
care you provide for our loved-ones, friends and neighbors with cancer. To all of my dear 
colleagues and friends at Centra, thank you for your understanding and support throughout my 
degree completion. Finally, an extra special thanks to my family and friends for patience during 
this long haul and to my DNP cohorts near and far who made this entire process extra 
meaningful.  
 
 
 
ADDRESSING BARRIERS TO ADHERENCE  7 
Table of Contents 
Contents  
Dedication ...................................................................................................................................... 5 
Acknowledgments ......................................................................................................................... 6 
List of Figures ................................................................................................................................ 9 
SECTION ONE: INTRODUCTION......................................................................................... 12 
Background ............................................................................................................................... 14 
Problem Statement .................................................................................................................... 20 
Purpose of the Project ............................................................................................................... 21 
Clinical Question ....................................................................................................................... 23 
SECTION TWO: LITERATURE REVIEW ........................................................................... 23 
Search Strategy .......................................................................................................................... 23 
Critical Appraisal of Literature ................................................................................................. 24 
Conceptual Framework/Model .................................................................................................. 42 
Theoretical Framework ............................................................................................................. 44 
Summary ................................................................................................................................... 46 
SECTION THREE: METHODOLOGY .................................................................................. 48 
Design........................................................................................................................................ 48 
Measurable Outcomes ............................................................................................................... 50 
Setting........................................................................................................................................ 50 
Population.................................................................................................................................. 51 
Ethical Considerations............................................................................................................... 53 
Data Collection .......................................................................................................................... 54 
Instruments ................................................................................................................................ 55 
Intervention ............................................................................................................................... 59 
Feasibility Analysis ................................................................................................................... 59 
Data Analysis ............................................................................................................................ 60 
SECTION FOUR: RESULTS .................................................................................................... 62 
Descriptive Statistics ................................................................................................................. 62 
SECTION FIVE: DISCUSSION ............................................................................................... 66 
Implication for Practice ............................................................................................................. 66 
ADDRESSING BARRIERS TO ADHERENCE  8 
Limitations ................................................................................................................................ 68 
Sustainability ............................................................................................................................. 71 
Dissemination Plan .................................................................................................................... 73 
References ..................................................................................................................................... 77 
APPENDIX A: Evidence Table ................................................................................................. 86 
APPENDIX B: Permission to use The Iowa Model Revised and Implementation Strategies 
for Evidence-Based Practice ................................................................................................. 110 
APPENDIX C: CITI Training Completion Certificate ......................................................... 111 
APPENDIX D: Medication Adherence Barrier Identification Instrument ......................... 115 
APPENDIX E: Letters of Support .......................................................................................... 120 
APPENDIX F: Institutional Review Board Approvals ......................................................... 123 
APPENDIX G: SPSS Coding Key and Comments ................................................................ 125 
 
  
ADDRESSING BARRIERS TO ADHERENCE  9 
List of Figures 
 
Figure 1. Washburn_Barrier to Medication Adherence Screening Instrument ............................ 57 
Figure 2. Classification Tree: Patients with Uncontrolled Illness or Event(s) ..............................64 
Figure 3. Classification Tree: Patients with Uncontrolled Illness or Event(s) and Related 
Medication Prescription ................................................................................................. 65 
  
ADDRESSING BARRIERS TO ADHERENCE  10 
List of Abbreviations  
American Medical Association (AMA) 
American Society of Clinical Oncology (ASCO) 
Cardiovascular Disease (CVD) 
Chronic Obstructive Pulmonary Disease (COPD) 
Centers for Disease Control and Prevention (CDC) 
Centers for Medicare and Medicaid Services (CMS) 
Continuing Medical Education (CME) 
Diabetes Mellitus Type 2 (DM-2) 
Doctor of Nursing Practice (DNP) 
Eastern Cooperative Oncology Group (ECOG) 
Electronic Medical Records (EMR) 
Hypertension (HTN) 
Institutional Review Board (IRB) 
Institute of Medicine (IOM) 
National Comprehensive Cancer Network (NCCN) 
Oncology Care Model (OCM) 
Oncology Nursing Society (ONS) 
ADDRESSING BARRIERS TO ADHERENCE  11 
Patient Health Questionnaire-9 (PHQ-9) 
Statistical Package for the Social Sciences (SPSS) 
The Joint Commission (TJC) 
Washburn-Barriers to Medication Adherence (W-BMA) 
World Health Organization (WHO) 
  
ADDRESSING BARRIERS TO ADHERENCE  12 
SECTION ONE: INTRODUCTION 
 
Adherence to a prescribed medication regimen is often critical to successful disease 
management. Non-communicable disease is expected to exceed 65% of the global burden of 
disease in 2020; however, 50% to 60% of patients are nonadherent to their prescribed treatment 
regimen (Lam & Fresco, 2015). Mental illness, diabetes mellitus type 2 (DM-2), cardiovascular 
disease (CVD), and/or chronic obstructive pulmonary disease (COPD) are common comorbid 
diseases seen with a primary diagnosis of cancer. Cancer diagnoses often further complicate 
control of the comorbid diseases, due to the often-overwhelming nature of cancer and its 
treatment on the patient and caregivers. Older cancer patients with multiple comorbidities 
receiving chemotherapy treatment are at increased risk for adverse health outcomes from 
uncontrolled disease when nonadherent to their medication regimen (Sarfati, Koczwara, & 
Jackson, 2016).  
The intent of this pilot study was to test the validity of an evidence-based screening 
instrument designed to identify patients at risk for medication nonadherence and uncontrolled 
illness. The goal was to compare the number of patients identified at risk with this instrument 
with those identified by current screening methods for depression and distress alone, and to 
assess the sensitivity of both methods. The Washburn-Barriers to Medication Adhere (W-BMA) 
requires more time and attention than the current depression and distress screens. If an equivocal 
number of patients can be initially identified without this instrument, there is no need to use it as 
an initial screening method. Instead, patients could simply be identified by their high depression 
or distress screening scores and then further evaluated at another time by the instrument being 
studied. So, this author felt it was important to compare results of the W-BMA screen to the 
current screening methods alone to ensure that it is a more reliable and sensitive instrument. The 
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W-BMA screening criteria were applied to retrospective data of cancer patients with multiple 
comorbidities. Addressing barriers to adherence can be complex and time-consuming for 
healthcare providers, depending on the type, number, and extent of barriers present. Healthcare 
providers around the country may not always have the needed evidence-based instruments and 
support to address these barriers. The literature analyzed for this project contains clear evidence 
that there are numerous barriers that are proven to impede adherence. Nonadherence that goes 
unidentified, and is not adequately addressed, subsequently increases risk of uncontrolled illness 
and adverse health outcomes to the patient (American Medical Association [AMA], 2018; 
Centers for Disease Control and Prevention [CDC], 2017a).  
An avoidable, adverse health outcome is not only detrimental to the patient, it also 
infringes on the time and resources needed for ongoing scheduled patient care and reduces 
reimbursement needed to help for efficient operation of the medical clinic. It is of growing 
importance for healthcare providers and the healthcare system to be as successful as possible in 
treating disease and managing health. In addition, The Joint Commission (TJC) and Centers for 
Medicare and Medicaid Services (CMS) both expect healthcare providers to assess inpatient and 
outpatient adherence to medication regimens and act on issues with adherence if possible (CDC, 
2017a; Cawthorn, Mion, Willens, Roumie, & Kripilani, 2014). A formal, evidence-based process 
to identify and address the most impactful barriers to medication adherence is needed to help 
improve outcomes, reduce healthcare costs, and meet the expectations of regulatory and 
accrediting agencies.  
Healthcare providers and patients may benefit from development of an efficient and 
effective evidence-based process to (a) identify signs of the most common, impactful barriers to 
medication adherence; (b) identify applicable resources to address each of these barriers; and (c) 
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consistently connect the patients to these resources. There is first, though, a need to develop a 
valid instrument that will assist healthcare providers to identify the individuals that have 
increased risk of adverse events from nonadherence to prescribed treatments. An instrument that 
is valid will fulfill its intended purpose. This pilot study tested the validity of an evidence-based 
screening instrument designed to screen individuals for potential barriers that are likely to 
decrease adherence to their prescribed medication regimen. 
Background 
 
The World Health Organization’s (WHO, 2003) definition of adherence is “the extent to 
which a person’s behavior corresponds with agreed recommendations from a healthcare 
provider.” This definition includes the initiation, continuation, and discontinuation of therapy as 
directed (Lam & Fresco, 2015; WHO, 2003). While working in the outpatient setting recently, 
over a nine-year period, this researcher detected multiple complexities to medication adherence. 
There are, in fact, as many as 42 significant specific barriers to medication adherence as detected 
in one extensive meta-analysis of research (Irwin & Johnson, 2015). These barriers make 
assisting patients with successful medication adherence very complex. In addition, it is very 
apparent that there is currently little resource and time allocation for in-depth assessment of 
barriers to successful home medication management in the typical clinical setting. This is by no 
means unusual as healthcare settings of all types are pressed to be as efficient as possible when 
providing patient care. Clinical staff are encumbered with many responsibilities with immediate 
impact on patient care, and very reluctant to add tasks to their already busy day. Current 
initiatives to address important patient safety metrics tend to be shadowed by priority tasks with 
more immediate consequences. With these impediments, it is also likely that many barriers 
remain undetected and unresolved.   
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In considering prevention of nonadherence, one might ask if there is any benefit to 
checking in with patients who are at lower risk of nonadherence to help keep them from 
becoming nonadherant. Referral to the cancer support team is not likely necessary for those who 
are already adhering to maintain adherence. According to Lafeuille et al (2016) a review of 
Medicaid claims included 12,990 patients with schizophrenia age 25 to 64 on at least one 
antipsychotic medication. Patients who showed adherence at baseline (regularly filled their 
prescription) continued to remain adherent, especially when maintained on one simple regimen 
and not switched (Lafeuille et al., 2016). It is more feasible and probably more impactful to 
target those with a higher likelihood of medication nonadherence. 
Impact of nonadherence. A CMS (2017a) report of national health expenditures for 
2015 states that 324.6 billion dollars (10.1% of total United States health expenditures [CDC, 
2017b]) was spent in that year alone on prescription drugs in the United States. Unfortunately, 
only about one quarter of medications are taken as prescribed (AMA, 2018; CDC, 2017a; Lam & 
Fresco, 2015). Various sources estimate that 50% to 70% of prescriptions make it to the 
pharmacy, 48% to 66% come out of a pharmacy, 25% to 30% are taken properly, and only 15% 
to 20% are refilled as prescribed (AMA, 2018; CDC, 2017a; Million Hearts, 2017). Patients who 
are Medicare/Medicaid eligible with three or more comorbidities and receiving chemotherapy 
are especially vulnerable to the consequences of nonadherence. Mental health and non-
communicable disease are expected to exceed 65% of the global burden of disease in 2020; 
however, 50% to 60% of patients (especially those with chronic diseases) are nonadherant to the 
medicine prescribed (Lam & Fresco, 2015).    
Comorbidities in cancer patients account for inferior survival rates (especially in adults 
diagnosed at an early age), poorer quality of life, and an increase in the cost of healthcare costs 
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compared to patients without comorbidities (Sarfati et al., 2016). CMS is taking special note of 
comorbidities previously not addressed during chart audits of its beneficiaries and TJC 
inspections of accredited organizations. One example is a new measure for diabetes that 
providers will be held accountable for and specifically examines adherence. One new measure is 
NQF 2468: Adherence to Oral Diabetes Agents for Individuals with Diabetes Mellitus. CMS will 
look at databases of individuals prescribed at least two oral diabetes agents in 12 months. 
Specifically, they will look at adherence to the oral diabetes medications by checking if 
prescriptions are filled. In addition, this measure is paired with two additional measures to check 
adherence to statins and ACEIs and ARBs for individuals with diabetes (CMS, 2017). 
Complexity of assessing barriers to adherence. There is great complexity in the 
concept of addressing barriers to adherence in an efficient and effective manner in a busy 
healthcare setting. Barriers may be numerous and intertwined in such a way that addressing a 
single barrier does not improve adherence. Many published efforts to address barriers to 
adherence discuss a single focus, such as literacy or reducing cost. At the University of 
Pennsylvania and Pennsylvania Presbyterian hospitals, 1,084 adult patients were surveyed to 
discover the issues they felt caused their readmission. The most common reasons included 
feeling unprepared for discharge, trouble with accessing medications, and lack of social support. 
Low socioeconomic status (Medicaid or uninsured) were more likely to report difficulty 
understanding and executing discharge instructions and adhering to medication regimens 
(Kangovi et al., 2012). In these examples, there may be many co-existing barriers that require 
alleviating to ensure successful medication adherence.  
Complications to addressing adherence arise from the patients and the providers. A study by 
Flink & Ekstedt (2016) in Sweden examined the use of an education instrument that they hoped 
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would be used by nursing staff to improve discharge teaching and medication compliance. 
Information was given at discharge; however, the level of education provided was primarily 
driven by the needs of the staff, as opposed to the patient's level of understanding. Although the 
aim of the study was to see if the new instrument and process would improve adherence, it 
proved to have no impact due to the time limitations of the nurses (Flink & Ekstedt, 2016). It is 
very important to consider the feasibility of a process, as well as the culture of the setting, when 
implementing a new practice. A multidisciplinary task force created an inpatient COPD pathway 
(Brewer et al, 2016) which included standardized medication orders. Respiratory Therapists were 
trained to follow the program which included discharge teaching and patient materials. The 
Respiratory Therapists found that the primary medical team was unwilling to order specialty 
service consults. The therapists also found that patients felt the reason they were readmitted is 
that they felt they had been discharged too early on the previous admission. More data was 
required to evaluate the effectiveness of their intervention.Similar experiences are common in 
the local healthcare facilities as well, so any process implemented must be feasible and accepted 
by those who are crucial to its implementation. Assessing if an intervention is feasible and 
acceptable also requires examination of the available resources. An additional pharmacist-driven 
study evaluated the impact of providing medications immediately upon discharge to patients 
admitted to a psychiatric unit and found that this improved adherence to the treatment regimen 
(Tomko et al., 2013). This type of intervention is only feasible when a dispensing pharmacy is 
readily available.  
 Balling, Erstad, & Weibel (2015) report that the impact of pharmacist provided education 
at patient discharge reduced readmission rates. In addition to 1,011 patients involved in the 
study, 452 interventions were required by the pharmacist to intercept issues with the discharge 
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medication list. Barriers to adherence can start in the clinic or hospital setting due to medication 
reconciliation discrepancies (Balling, Erstad, & Weibel, 2015). Additionally, phone calls from 
pharmacists have been shown to reduce rates of rehospitalizations of cancer patients when the 
patients’ adherence was assessed, questions answered, and any discrepancies addressed within 
30 days of discharge (Patel, Nguyen, Bachler, & Atkinson, 2017). Again, although these were 
effective interventions, it is not feasible if it cannot be sustained. Pharmacy personnel in the 
healthcare setting are rarely available for consistently making follow up phone calls, or 
performing medication reconciliations.  
 To summarize the discussion of complexity, the feasibility of creating a new screening 
instrument may be questioned due to the existence of current instruments that can be used to 
assess medication adherence. One such questionnaire is called the 8-item Morisky Medication 
Adherence Scale, which is a validated instrument used to assess patients’ medication taking 
behavior and barriers to adherence. It is considered a highly reliable instrument in patients with 
chronic diseases (Lam & Fresco, 2015). The scale is a patient questionnaire addressing 
forgetfulness, or choosing not to take a medication; however, it does not screen for some 
additional common impactful barriers such as financial constraints and educational barriers. It 
also relies on the patient to provide thoughtful, honest answers. This may also prove to be 
complex. To effectively impact adherence and reduce risk of uncontrolled illness with resulting 
adverse medical events, the complexities of this problem must be addressed. Clinic staff must 
have the time, support, and motivation to use a process consistently and as it is intended, for it to 
have the best impact on outcomes.  
 Current efforts to address barriers to adherence. The retrospective data used in this 
evidence-based research study was from records of patients treated at a local outpatient oncology 
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clinic. The clinic is one of a few hundred in the nation to achieve recognition for their quality 
care of oncology patients.  Current quality assessments collected by the American Society of 
Clinical Oncology’s (ASCO, 2016) Quality Oncology Practice Initiative report instrument 
indicate that medication follow up falls somewhat below standards in many outpatient 
institutions. CMS (2018) tracks outpatient quality measures, and according to their website, they 
plan to begin focusing on patients receiving outpatient chemotherapy. The local oncology clinic 
was involved in a pilot CMS program called the Oncology Care Model (CMS, n.d.). The 
Oncology Clinic in which this project was completed is one of 191 current practices taking part 
in the model. Patients who have had cancer treatment within 6 months and are eligible for 
Medicare benefits are enrolled in the oncology care model (OCM) cohort at the Hematology 
Oncology Clinic. The CMS expects OCM patients to receive enhanced services including care 
coordination and improved care plans to help prevent emergency room visits and hospitalization 
from the start of chemotherapy and for 6 months following a dose of chemotherapy. Barriers to 
medication adherence may result in unnecessary emergency room visits and/or hospitalization. 
There are many cancer care support system resources available, including navigators, social 
workers, care coordinators, and others who are in a unique position to assist the patients. 
However, like the vast numbers of care providers in the nation, they may not always have 
awareness of some of the most impactful needs of the patient. The intent of this pilot study was 
to test the validity of an evidence-based screening instrument intended to aid in identification of 
the most impactful barriers that decrease adherence to prescribed medications. It is hoped that 
reporting of this project creates awareness and an impetus for healthcare providers to screen for 
barriers and partner with other professionals in healthcare and community resources to find 
solutions to one of the most challenging patient care issues, medication adherence.  
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 Implications for practice. Comorbidities in cancer patients account for inferior survival 
rates (especially in adults diagnosed at an early age), poorer quality of life, and an increase in the 
cost of healthcare costs compared to patients without comorbidities (Sarfati et al., 2016). When 
adding the consequences of nonadherence to the prescribed treatment regimen, the impact can be 
devastating. Mausbach, Scwab, and Irwin (2015) and Sarfati et al. (2016) stated that nurses can 
improve evidence-based practice guidelines for patients with comorbidities. This includes 
guidelines to both identify and address barriers to medication adherence. In such, nurses at all 
levels of practice can make a direct impact on mortality, cost of care, and quality of life 
(American Association of Colleges of Nurses, 2006). The healthcare system both locally, and as 
a whole, is impacted financially by medication nonadherence due to unplanned office visits, 
emergency department visits, or hospitalizations (CMS, 2017a, 2017b). One or more factors may 
comprise the barriers to adherence for a patient. These barriers may be intentional or 
unintentional, intertwined or independent, and might include financial, psychological, 
educational, medical, and behavioral components (AMA, 2018; Irwin & Johnson, 2015; ONS, 
2016). Healthcare providers desire to understand how best to treat an individual’s medical 
condition and deliver the best quality of care possible, while also working with healthcare 
administration to provide this care as efficiently as possible. Understanding what barriers exist 
for each patient that may prevent them from adhering to a prescribed treatment regimen is 
necessary for tailoring a treatment plan. There must also be a connection made to the resources 
that are available in answer to those barriers. 
Problem Statement  
 
 Oncology healthcare providers and cancer care support staff currently lack a formal 
evidence-based process to assess for the most common, impactful barriers to successful 
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medication adherence. Medication non-adherence is especially impactful in older cancer patients 
who have had cancer treatments. Individuals with warning signs of barriers to adherence may 
benefit from a referral to a member of the cancer care services support team, such as a navigator. 
Navigators and other support team personnel are currently available, and work with patients at 
various stages in their cancer journey. However, there currently is no instrument for providers to 
use for identification of the most common impactful barriers to care. Neither is there a 
consistent, formal process to help connect these individuals to locally available, applicable 
resources. A valid, evidence-based instrument to identify and address the most impactful barriers 
to medication adherence may help improve outcomes, reduce healthcare costs, and help meet the 
expectations of regulatory and accrediting agencies. Local healthcare providers do not currently 
have a valid, efficient evidence-based process to (a) identify warning signs of the most common, 
impactful barriers to medication adherence; (b) identify the applicable resources for each of these 
barriers; and, (c) consistently connect the patients to available resources. Due to the complexities 
of these steps, research must begin with a focus on the initial step of correctly identifying the 
population at risk. This is a pilot study to test the validity of an evidence-based screening 
instrument that identifies the most common, impactful barriers to medication adherence. 
Purpose of the Project  
 
The purpose of this study was to test the validity of an evidence-based instrument to 
screen for the most common, impactful barriers to medication adherence and evaluate if it was a 
more sensitive indicator of risk than the current screening methods alone. This instrument was 
tested on retrospective data of high-risk oncology patients. The pilot study evaluated the validity 
of the instrument, to see if it accurately identified CMS beneficiary cancer patients who had 
barriers to medication adherence and as a result, were more likely to have uncontrolled illness. 
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Patients who have some obvious warning signs of medication nonadherence, who are at high risk 
for emergency room use and hospitalization are currently referred, on occasion, to navigators for 
coordination of resource access and referral. It is hypothesized from information abstracted from 
the literature review in this project, that increasing intervention efforts to eliminate certain 
barriers to medication adherence will subsequently improve disease control, thus lowering the 
potential risk of emergency room use and hospitalization. Currently, the only warning sign to 
barriers for which referrals are consistently made, via use of validated instruments, is depression 
and distress. While depression is a significant barrier, and distress may result in adherence issues 
as well, they are not the only significant barriers found in literature. Oncology patients are also 
initially referred to a financial counselor to discuss costs specific to their cancer treatment; 
however, additional financial assistance may be needed further into the treatment period. Unless 
the patient reaches out for assistance, this barrier may go undetected. Additional barriers 
identified in the literature will benefit from intervention to help ensure that cancer patients 
remain as healthy as possible during their cancer treatments and recovery.  
The reliability of the test was evaluated as well. Specificity was tested by analyzing the 
instrument’s ability to identify, not only an increased number of patients at risk compared to 
informal referrals, but also whether or not the patients identified also have an increased 
percentage of uncontrolled illness, so as to minimize false identification of patients who are not 
at increased risk.  For the instrument to be beneficial, it must not only correctly identify high-risk 
individuals, it must also not falsely identify an unacceptable number of individuals who are not 
truly at risk. This would make screening an unwieldy task that is too burdensome for the 
healthcare system. There may need to be some alterations made to the instrument, and additional 
future testing to ensure this is a useful instrument. The goal is to eventually introduce the 
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assessment instrument into practice and increase referrals to navigators who then can coordinate 
resources to assist patients with treatment adherence. 
Clinical Question  
 
 In a one-year retrospective review of CMS eligible outpatient records, does the use of a 
new evidence-based screening instrument developed from literature, compared to current 
screening methods alone, increase identification of patients with barriers to medication 
adherence? 
SECTION TWO: LITERATURE REVIEW 
 
Search Strategy  
 
A search of CINAHL Plus with Full Text, Cochrane Library, JAMA, Journals@Ovid, 
MEDLINE, MEDLINE with Full-Text (EBSCO), Nursing and Allied Health, and ProQuest was 
completed. The keywords and Phrases used for the search included readmission, 
rehospitalizations, cancer, oncology, diabetes type 2, depression, behavior, comorbidities, 
medication(s), adherence, nonadherence, compliance, noncompliance, barriers, obstacles, 
challenges, difficulties, issues, stigma, predictors, predicting, causes, drug therapy, 
polypharmacy, prescriptions, providers, outcomes, quality of  life, algorithm, toolkit, 
questionnaire, assessment, instrument. Parameters of the search were journal articles published, 
peer-reviewed, written in English with a focus on studies completed in the United States within 
five years. Literature generally up to seven years were included if data used was not primarily 
older than ten years. Additional searches were completed in the Liberty University Special 
Collections database and on the websites of the Centers for Disease Control, Centers for 
Medicare and Medicaid Services, Hospital Compare (Hospital Compare, n.d.), Kaiser Family 
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Foundation, Oncology Nursing Society, American Medical Association, AHRQ, World Health 
Organization, and the Patient Engagement Health Information Technology website.  
Bibliographies were searched in articles and presentations for primary sources when 
needed. Research articles, using data more than ten years old, were discarded as were articles 
with insufficient data or concerning limitations. Also discarded were studies that identified 
barriers, or interventions not supported by the preponderance of the literature. In some cases, 
such as research on the impact of financial burden, literacy, and education on nonadherence, 
there was such an overwhelming amount of evidence that only a limited number of articles on 
those topics was retained and included. Melnyk Levels of Evidence was used to analyze the 
literature used in this project and includes Levels 1 through 7 with Level 1 systematic reviews, 
meta-analysis, meta-analysis with triangulation, clinical guidelines based on systematic reviews, 
and meta-analysis were given the most credence when evaluating evidence for impact of barriers 
and interventions. In all, 990 articles were reviewed and saved to EndNote for retrieval, while an 
additional number of electronic databases and information retrieved from both paper and online 
journals and textbooks were not counted. Out of those 990 research articles, 29 research articles 
accompanied by 26 additional reliable sources of evidence were deemed to be applicable and 
sufficient for creation of an evidence-based instrument for identifying potential adherence 
barriers and increasing patient referrals to effective resources for adherence issues.   
Critical Appraisal of Literature 
 
Select resources used for instrument development. In researching various possible 
resources to implement in the clinical setting, several helpful toolkits were analyzed. Each one 
has been proven to be effective in its own way and for the purpose for which it was developed. A 
universal precautions toolkit exists for addressing low literacy in the healthcare setting. This 
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article (Weiss et al., 2016) emphasizes and recommends brown bag reviews of medication, as 
opposed to review of electronic or printed medication lists, for accuracy of assessment to help 
avoid issues caused by low literacy.  
Routine medication reviews are completed regularly in clinical practice; however, it can 
be difficult to get an accurate picture of adherence during a brief and usually verbal review of 
medications. The “Universal Precautions” toolkit helps address literacy issues in medication 
adherence (Weiss et al., 2016). In this research review, patients were encouraged to bring their 
medications to the office so that a visual inspection could be performed. Bringing the 
medications resulted in a doubling of the number of drug therapy problems identified, as well as 
a doubling of the percentage of medication regimens revised. The office currently utilizes this for 
all new patients, as well as any patients who may be having difficulty with their medications. Not 
all physicians require this of all patients at every visit as suggested in this study. 
 The Oncology Nursing Society (ONS, 2016) developed an oral adherence toolkit with 
several individual instruments that may help assess and improve adherence. ONS has provided a 
similar toolkit for several years; the most recent updated in 2016. There are 13 individual 
instruments within the toolkit that may be used for assessing adherence, identifying risk factors, 
guiding patient education, identifying reimbursement and financial assistance resources, 
identifying food, drug and pathway interactions, sample treatment tracking calendars, methods to 
motivate, encourage, reconcile, and track medication adherence. In addition, there is an 
instrument that can be used to track readiness to change. According to ONS, patients may be able 
to provide their own warning of potential nonadherence by acknowledging they are not ready to 
change which includes starting a new therapy. Lastly, there is a resource list for patients and 
providers to aid in finding drug and cancer information, along with teaching materials from some 
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of the most reliable resources on cancer and pharmaceuticals. The toolkit contains a list of 13 
patient assistance and reimbursement resources for helping cancer patients afford their 
medications. This toolkit contains very useful ideas for helping oncology nurses assist patients in 
adhering to their medication regimens. As previously stated, it may be difficult for clinical nurses 
to have the time to devote to the measures suggested in this toolkit. However, the individual 
instruments are evidence-based methods of helping patients overcome barriers to adherence.  
The AMA (2018) Stepsforward education material and toolkit provides an education with 
CME credit available to healthcare providers along with a toolkit and support to help address 
nonadherence issues in their practice. The AMA cites eight steps to addressing nonadherence: (1) 
consider nonadherence first as the reason a patient’s condition is not under control because 
“patients do not take their medications half the time” (par. 1); (2) develop a process for routinely 
asking about medication adherence; (3) create a blame-free environment to discuss medications 
with the patient; (4) identify why the patient is not taking their medication (eight common 
reasons are cited including: fear, cost, misunderstanding, lack of symptoms, depression, too 
many medications, worry, and mistrust); (5) respond positively and thank the patient for sharing 
their behavior; (6) tailor the adherence solution to the individual patient; (7) involve the patient 
in developing their treatment plan; and, (8) set up patients for success. The online education 
module accompanying this toolkit has an excellent educational component that is very quick and 
interesting to complete. It is a great guide in helping physicians and other healthcare 
professionals in discussions with patients regarding adherence.  
These toolkits provide helpful guidelines for addressing some of the barriers that exist to 
medication adherence. An important emphasis is that of having an open and trusting relationship 
with the patient, as well as time to have the discussion about possible barriers. These toolkits and 
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guidelines are helpful for a focused subset of barriers and encouraging discussion; however, a 
more comprehensive screening instrument accompanied by purposeful interventions organized 
by dedicated staff may be more impactful in today’s very complex patients. 
  Appraisal of literature for categorized barriers. Following are five categories of 
major adherence barriers, listed in order of impact, found in the literature to be the most 
commonly reported, most potentially impactful, and most feasibly actionable, with the 
accompanying research and comments.   
Financial and social barriers. Cost can be a deterrent to filling prescriptions; patients do 
not fill their prescriptions about a quarter of the time, and do not take them about half of the time 
(AMA, 2018). Single marital status, lower income, and having more than 10 medications were 
significantly associated with not filling medications. Reasons included cost by 23.5% of patients. 
Additional reasons include lack of time to go to the pharmacy, medication not delivered or 
dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus, & 
Kripalani, 2016). Hanson, Habibi, Khamo, Abdou & Stubbings (2014) conducted a pharmacy 
study to examine whether connecting patients with a team to help address the prohibitive 
expense of multiple sclerosis drugs would improve adherence. It was in fact proven helpful, 
although the team concept involving advanced providers was an expensive concept that would be 
difficult to reproduce and sustain. The cancer center employs financial navigators, social 
workers, and nurse navigators who may provide a more sustainable coordination of care.     
Three major factors predict whether a patient can afford medication: (a) insurance 
coverage, (b) overall health, and (c) income. In addition, individuals who make under $50,000 a 
year in income are more likely to skip doses or stop taking their medication than individuals with 
higher income (National Community Pharmacists Association [NCPA], 2013). In a New York 
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Times online journal article, Frakt (2017) cited systematic reviews and randomized control trials 
analyzing several methods to address adherence, such as electronic reminders, pill organizers, 
and electronic reminder and feedback systems. The author concluded that reduced price, or free 
medications, are the only consistent predictors that patients will take and refill medication as 
directed: “For those with certain chronic conditions, extra help in affording medications can 
reduce adverse events and hospitalizations” (Frakt, 2017). 
 One in five adults reported taking at least four prescription drugs with 55% taking at 
least one. About 35% of patients taking four or more prescription pills reported taking lower 
dosage or skipped doses (and, if uninsured did not fill the prescription) compared to 25% of 
those taking three or fewer. Income of $40,000 a year or less was another predictive factor of 
lowering, skipping, or not filling a prescription (Kaiser Family Foundation, 2017a). Roop and 
Wu (2014) conducted an online survey of 5,000 oncology nurses. Of those nurses, 577 nurses 
responded and 51% of the nurses worked in practices that had developed specific policies, 
procedures, and resources for patients taking oral therapy. One of the most frequently identified 
barriers to adherence was cost. Irwin and Johnson (2015) cited cost or lack of insurance coverage 
was mentioned 26% of the time, and social support was a reported factor of nonadherence 32% 
of the time in their meta-analysis of qualitative research with triangulation to quantitative studies. 
At the University of Pennsylvania and Pennsylvania Presbyterian hospitals, 1,084 adults were 
surveyed to discover the issues they felt caused their readmission. Among the most common 
reasons included low socioeconomic status (Medicaid or uninsured) driven barriers of obtaining 
and adhering to medication regimens (Kangovi et al., 2012).  
Additional financial and social barriers include marital status and geography (where the 
patient lives in relationship to healthcare and pharmacy). Single marital status is a significant 
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predictor of nonadherence according to one study (Greer et al., 2016). Multimorbidity was 
present in 36% of patients in a study of over 4,000 patients in the Netherlands by Aarts et al., 
(2015). In this review, low socioeconomic status was associated with increased comorbidities 
(70% vs. 61%); cardio and cerebrovascular diseases negatively impacted survival. One-year 
survival rate was 22% without comorbidity and 13% with Multimorbidity (Aarts et al., 2015). 
Geography is a type of social barrier that can be a significant hindrance for patients who live in 
rural areas, especially without reliable internet service (Heath, 2017). 
Associated suggested warning signs. Financial and social warning signs include:  
Uncontrolled illness; Unfilled prescriptions or refills; Pill bottle contains more pills than it 
should based on fill date; Weekly pill container contains unopened days/unused pills; Patient 
comments on cost of care or states “Trying to save money”; Self-reported absence of social 
support; and Difficulty “getting into town” to make appointments (AMA, 2018; CDC, 2017a; 
Greer et al., 2016; Heath, 2017). 
 Associated examples of recommendations/resources/expert advice supported by 
literature.   
Associated examples of recommendations, resources and expert advice supported by literature 
include: 
1. Consider lower cost medications (CDC, 2017a). Many methods of encouraging 
adherence may lack sufficient data to prove efficacy. However, providing free or low-
cost drugs is a well-supported, effective intervention (Frakt, 2017). 
2. Referral to oncology nurse navigator for coordination of interventions and care: 
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• The patient may choose not to spend money on medications for many reasons. 
However, if patient is eligible for assistance, explore whether patient knows about 
available resources and understands how to utilize these resources.   
• If an employee, provide with the health network resource information through human 
resources providing free financial counseling services. 
• Refer to oncology social worker and/or financial counselor. Often, these individuals 
will access pharmaceutical, pharmacy, and laboratories that often have patient 
assistance programs which many times can be located on their website or made 
available by calling their main contact numbers. Patient may also need assistance 
understanding Medicare/Medicaid benefits and services. 
• ONS (2016) Oral Adherence Toolkit contains a list of thirteen reimbursement and 
patient assistance resources.  
• Consider living situation and location, access to transportation, fuel, and availability 
of reliable internet and/or phone service before recommending services that require 
travel or internet-based interventions such as telehealth classes.  
• Consider community health partnerships such as paramedic program to check on 
health and well-being as well as home environment safety check (Heath, 2017).  
• There is not a one-size-fits-all method to encourage adherence, so it is important to 
tailor each individual’s treatment plan to their needs to avoid waste. However, in all 
cases, efforts to lower cost of medication for patients results in better adherence 
according to the literature. 
Depression/distress/anxiety. In a meta-analysis by Mausbach et al. (2015), over 17,000 
women were evaluated for association of depression and adherence to oral anticancer therapy. 
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Greater depression was in fact associated with lower adherence. This resulted in increased 
mortality, increased medical costs, and worsened quality of life. Patients who are depressed or 
anxious are less likely to take their medications (AMA, 2018). If a patient has a history of mental 
health disorders, such as depression, anxiety, or addiction, he or she is less likely to adhere to 
their medication regimen (Million Hearts, 2017). 
Greer et al. (2016), in a systematic review of adherence to oral chemotherapy agents, 
reported that depression played a significant role in nonadherence, with some rates dropping to 
about 50% at the five-year follow up. Adjuvant endocrine therapy adherence was lower in 
women with depressive symptoms, especially in younger women just starting endocrine therapy. 
Individuals with depression have greater non-adherence than patients without depressive 
symptoms. In this study, women with lower adherence were also found to have a shorter time to 
recurrence of their cancer, increased medical costs and worsened quality of life (Bender et al, 
2014; Mausbach et al., 2015). Long-term distress may be a predictor of non-adherence (Aikens, 
Trivedi, Aron, & Piette, 2015).  
Associated suggested warning signs. Associated suggested warning signs include: 
Uncontrolled illness; PHQ-9 Depression screen Score of 15 or higher (Patient fills out PHQ-2 
followed [if indicated] by the PHQ-9 questionnaire). A score of 15 or higher on PHQ-9 indicates 
a moderately severe depression barring other causes such as thyroid disorder (Maurer, 2012); 
NCCN Distress Score of 4 or higher; and Anxiety. 
 Associated examples of recommendations/resources/expert advice supported by 
literature. 
Associated examples of recommendations, resources, and expert advice supported by 
literature include: 
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1. Consider antidepressants. The AMA (2018) recommends treatment of depression to aid 
in better adherence, and the ONS provides information gleaned from an extensive review 
of literature on medication adherence. Treatment of depression is found to be an 
intervention that is likely to be effective to increase adherence to prescribed treatments 
(Spoelstra, & Sansoucie, 2015). 
2. Referral to oncology nurse navigator for coordination of interventions and care: 
• Early treatment of depressive symptoms (Mausbach et al., 2015; Spoelstra & 
Sansoucie, 2015).   
• Confirm that physician has been notified of PHQ-9 score of 15 or higher and consider 
work up and/or referral to mental health professional.  
• Connect with family or social support 
• Healthcare institutions’ mental health web page often lists various resources for 
support of depression and other mental health issues.  
• If employee, provide with resource information through human resource 
partners to explore possible availability of free financial counseling services. 
Medical. (Includes Side effects/Effectiveness/Medication Reconciliation 
Issues/relationship with provider/multiple comorbidities/Polypharmacy) Murphy, Bartholomew, 
Carpentier, Bluethmann, and Vernon (2012) reviewed 29 peer-reviewed primary studies of 
female breast cancer survivors taking endocrine therapy published between 1998 and 2012. 
Nonadherence rates were as high as 71% at five years. Factors in this category found worsened 
adherence included older age and side effects. Although this study is older, it provides an 
important level one review of data that is still applicable today and supported by additional 
research, especially concerning older age and side effects. The previously mentioned study by 
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Roop and Wu (2014) found that one of the most frequently identified barriers to adherence was 
adverse effects of the medication. 
The greater the number of different medications prescribed and the higher the frequency, 
the more likely that a patient will be nonadherant to their medication regimen (AMA, 2018). The 
relationship to the provider is also a predictive factor in adherence. “Mutually respectful 
collaboration with providers” is one key to improving adherence (CDC, 2017a). A meta-analysis 
of qualitative research with triangulation to quantitative research revealed a 42% frequency of 
provider relationship as a predictor of adherence in the qualitative literature. A positive 
relationship facilitates adherence while a negative relationship does the opposite (Irwin, & 
Johnson, 2015). 
Additionally, advertisements, news coverage, and stories can have a negative effect 
and/or cause mistrust. Patients are less likely to fill their prescription if they do not trust the 
prescriber (AMA, 2018). Side effects were also common reasons for stopping medication in 21% 
of self-reported reasons for nonadherence in a national telephone survey of 1,020 adults with 
chronic illness and four or more medications (NCPA, 2013). Side effects were found 40% of the 
time in the qualitative literature in a meta-analysis of research regarding nonadherence (Irwin, & 
Johnson, 2015). A qualitative study of Turkish migrants with type 2 diabetes found that 
nonadherence may be impacted by different beliefs about medications (Peeters et al., 2015).  
Barriers do not always originate with the patient. Barriers to adherence can start in the 
clinic or hospital setting due to medication reconciliation discrepancies (Balling et al., 2015). 
Although questionnaires can be time prohibitive to administer, some can be effective for 
assessing nonadherence. Effective interviewing is an easy, low-cost method to assess a patient’s 
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adherence. Although knowledge may not accurately reflect adherence, knowing that they will be 
asked about medications by their provider may encourage adherence (Lam & Fresco, 2015).  
As mentioned in the financial and social category, single marital status, lower income, 
and having more than 10 medications were significantly associated with not filling medications. 
Reasons included cost by 23.5% of patients. Additional reasons include lack of time to go to the 
pharmacy, medication not delivered or dispensed, and inability to afford the medications 
(Wooldridge et al., 2016). 
Associated suggested warning signs. Associated suggested warning signs include: 
Uncontrolled illness; lack of expected side effects; Distressed about side effects; prescription not 
filled or refilled at expected rate; Late stage of cancer; Poor physical status; provider relationship 
strained; no show for appointments and reluctance to reschedule; requesting a different provider; 
patients’ significant other expresses concerns about patient not following treatment regimen 
(AMA, 2018; CDC, 2017a; Irwin & Johnson, 2015; Verbrugghe, Verhaeghe, Lauwaert, 
Beeckman, & Van Hecke, 2013). 
Associated examples of recommendations/resources/expert advice supported by 
literature. 
Associated examples of recommendations, resources, and expert advice supported by 
literature include: 
1. Minimize side effects (CDC, 2017a). 
2. Referral to oncology nurse navigator for coordination of interventions and care: 
• Follow up with phone calls to assess adherence, answer questions, and address any 
discrepancies (Patel et al., 2017).  
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• Assess patients for possible perspectives of medication based on ethnic beliefs 
(Peeters et al., 2015).  
• Consider motivational interviewing as opposed to traditional counseling to develop a 
rapport with patient to enhance trust and adherence to prescribed therapies (ONS, 
2016). 
• Encourage patients to stick with regimen for medications that tend to become more 
tolerant over time.  
• Assess for medication reconciliation errors and drug-drug or drug-food interactions. 
• Some medications can be taken at bedtime to ensure that the period with most 
prominent side effects occur during sleep. 
• Early follow up with medication reconciliation is important (Balling et al., 2015).  
• Follow up with patients who have missed follow up appointments 
Behavioral/lifestyle. (Associated themes: Forgetting/Don't think it's needed/Didn't 
"agree" to take it/Don't like taking it/ too busy/Away from home/no established routine). 
Forgetting was the number one self-reported reason for nonadherence in a national telephone 
survey (NCPA, 2013). However, additional research reviews of studies comparing reminder 
methods to control groups revealed that this may not be as large of an impact as previously 
reported (Frakt, 2017). Frequency of forgetfulness was 38% and doubting necessity was 35% in 
a meta-analysis of research with triangulation (Irwin & Johnson, 2015). In the same study, pill 
burden is mentioned with 25% frequency and regimen complexity 22% of the time.  
As mentioned in the financial and social category, single marital status, lower income, 
and having more than 10 medications were significantly associated with not filling medications. 
Reasons included cost by 23.5% of patients. Patients who express that they are tired of taking 
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medications are providing a warning sign that they are nonadherant (Million Hearts, 2017). 
Additional reasons include lack of time to go to the pharmacy, medication not delivered or 
dispensed, and inability to afford the medications (Wooldridge et al., 2016). 
Associated suggested warning signs.  Associated suggested warning signs include: 
Uncontrolled illness; Prescription not refilled at expected intervals; Pill bottle contains more pills 
than it should (check fill date); forgets; complains of being tired of taking medications, or too 
many medications; weekly/daily pill box contains unopened/unused pills; reluctance to accept a 
change in regimen; preference to be “prescription free” or “all natural” or other alternatives 
(Irwin & Johnson, 2015; Million Hearts, 2017; NCPA, 2013; Wooldridge et al., 2013). 
Associated examples of recommendations/resources/expert advice supported by 
literature. 
Associated examples of recommendations, resources, and expert advice supported by 
literature include: 
1. The S.I.M.P.L.E. method recommended by the Million Hearts (2017) program may help 
improve adherence. S.I.M.P.L.E. stands for Simplify the regimen; Impart knowledge; 
Modify the patients’ beliefs and behavior; Provide communication and trust; Leave the 
bias; and Evaluate adherence (Million Hearts, 2017). 
2. As previously mentioned, the study by Murphy et al. (2012) found factors such as 
switching therapies to make regimens easier improve adherence, and behavioral factors 
that improved therapy were referral and follow up by an oncologist for specific oncology 
therapy; otherwise, patients tend to discontinue their oncology therapies earlier than 
recommended. 
3. Referral to oncology nurse navigator for coordination of interventions and care: 
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• Methods to encourage patient adherence recommended by ONS (2016) include 
reminder instruments such as calendars, pill diaries, pill boxes with compartments for 
time of day for each day of the week, electronic reminders such as alarms, timers, 
smartphone apps, glowing or electronic pill containers, and medication dispensing 
machines. 
• Involve support systems, encourage routines, review at each visit, and reminder calls 
(CDC, 2017a).  
• Medication that requires taking with or without food or limits a food that is desired, 
such as grapefruit, can deter adherence. Work with patient to find a compromise or 
alternative therapy. 
• Taylor interventions to patient to assess methods of remembering medications. Try 
less expensive methods first, such as a daily pill container, because more expensive 
electronic reminders have not proven to make a more significant impact (Frakt, 
2017). 
• Patient monitoring and multicomponent feedback such as blood pressure checks and 
communication with provider office combined with education are most likely to be 
effective for adherence especially as it relates to forgetting or ambivalence (Spoelstra, 
& Sansoucie, 2015).  
• Patients most often forget their medications in the evening, weekends (especially 
Sunday), and holidays. Encourage patients to use a consistent method to remember 
medications even during these times that routine may change (Vervloet et al., 2013). 
Examples of reminders that may help are combinations such as smartphone reminder 
apps and travel cases for taking medication away from home. 
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 Educational. (knowledge deficits including general knowledge/limited English 
proficiency/functional/Cognitive/Psychological limitation; also, Literacy/Health literacy/Vision 
Impairment limiting ability to read educational materials/Memory 
impairment/misconceptions/distrust) Education appears to be one of the most studied methods of 
improving medication adherence. However, in relationship to the first four barriers above, the 
impact of education is less supported by the literature discovered in this review. One can find 
individual studies that support education and show limited improvement. However, it is 
important to note that one-time education without additional support or follow up drops off in 
effectiveness over time according to the literature.  
Barthélémy et al. (2014) studied patient adherence to oral targeted therapies, hormonal 
therapies, chemotherapies, and their attitudes, in a prospective study of 201 cancer patients. 
Patients who took hormonal therapies for five or more years tended to drop off in adherence. 
Patients were asked how well informed they felt about their therapy. The researchers concluded 
that patients who were better informed had better adherence. The researchers concluded by 
suggesting that better education and education repeated at intervals throughout the therapy time 
period could be beneficial to increasing adherence to oral therapies of all types. This article 
supports initial and ongoing education as an effective means of increasing medication adherence.  
A randomized controlled trial conducted by Moss, Lowe, Frampton, and Revell (2014) of 
45 hospitalized patients being discharged on warfarin were divided into two groups: one 
receiving the usual care, and the other provided with structured counseling and an educational 
video. Both groups were administered questionnaires at discharge and again at 3 months. Both 
groups were also assessed for satisfaction and time in therapeutic INR. Patients who received the 
intervention had significantly better knowledge of their therapy than the control group. In 
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addition, they also reported improved satisfaction and better time in the target INR range. This 
study suggests that a structured educational program at implementation of an oral medication 
improves knowledge, satisfaction, and therapeutic benefits of the drug.  
Predictors of nonadherence include limited English language proficiency, low literacy, 
and patient states he/she does not believe in the benefits of medication or believes they are not 
necessary or even harmful (Million Hearts, 2017). Patients who do not understand the purpose, 
side effects, or expected time before it is effective may result in nonadherence. This is true in 
patients with chronic illness because there is often no obvious result, so the patient may think it 
is not doing anything for them and stop taking it (AMA, 2018). The ONS review of literature 
recommendations suggest that in 2014 there was not enough information to establish education 
as an effective means of promoting adherence (Spoelstra, & Sansoucie, 2015). However, an 
additional study published by the ONS in 2015 cites medication knowledge was mentioned 25% 
of the time as a barrier to adherence in an extensive meta-analysis of qualitative studies 
triangulated with quantitative studies (Irwin & Johnson, 2015).  
A TJC study (Cawthon, Mion, Willens, Roumie & Kripalani, 2014) assessing the 
feasibility of a three-question literacy instrument states that addressing health literacy is a 
national health priority, and Standard PC.02.02.01 is reflected in the statement suggesting that 
the hospital effectively communicates to patients when providing care, treatment, and services 
(par. 2). TJC defines health literacy as “the degree to which individuals have the capacity to 
obtain, process, and understand basic health information and services needed to make 
appropriate health decisions” (par. 1). It is a necessary skill for successful navigation of the 
health care system, communication with providers, and management of chronic conditions. 
However, an estimated 90 million adults in the United States have low health literacy which is 
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associated with lower rates of preventive care, poorer disease control, and greater mortality, as 
well as increased health care utilization and costs (Cawthon et al., 2014). Inability to read and 
understand directions on pill bottle labels may be due to small print, confusing medical terms, or 
abbreviations (CDC, 2017a). Patients with higher levels of education typically are correlated 
with better health, have had more health education, and can advocate better for themselves 
(Heath, 2017). 
A structured, nurse-led teaching program that included follow-up phone calls at set 
intervals had encouraging results in lung cancer patients taking an oral chemotherapy drug 
(Boucher, Lucca, Hooper, Pedulla, & Berry, 2015). In a systematic review of randomized control 
trials, it was proven that group psychoeducation was effective in improving medication 
adherence in adults suffering from schizophrenia (Al-Batran, 2015). A study conducted by 
pharmacists at MD Anderson Cancer Center in Texas showed reduced hospitalization when 
patients were contacted by a pharmacist within 30 days of discharge to have adherence assessed, 
questions answered, and any discrepancies addressed (Patel et al., 2017). An additional 
pharmacist-driven study evaluated the impact of providing medications immediately upon 
discharge to patients admitted to a psychiatric unit and found that this improved adherence to the 
treatment regimen (Tomko et al., 2013). This is not feasible when a dispensing pharmacy is not 
readily available. However, it may be helpful to utilize this method if available in the future. 
 To discover the issues they felt caused their readmission, 1,084 adult patients were 
surveyed. The most common reasons included feeling unprepared for discharge and lack of 
social support. Low socioeconomic status (Medicaid or uninsured) were more likely to report 
difficulty understanding and executing discharge instructions (Kangovi et al., 2012). 
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Associated suggested warning signs.  Associated suggested warning signs include: 
Uncontrolled illness; Reluctance, difficulty, or inability to read and/or understand pill bottle or 
written instructions when asked; medication not taken correctly; calls pills by color, size, and 
shape but cannot tell you what they are for; has not filled prescription; significant other takes 
care of all paperwork, low socioeconomic status (AMA, 2018; CDC, 2017a; Irwin & Johnson, 
2015). 
Associated examples of recommendations/resources/expert advice supported by 
literature. 
Associated examples of recommendations, resources, and expert advice supported by 
literature include: 
1. Reduce complexity of regimen. 
2. Referral to oncology nurse navigator for coordination of interventions and care: 
• Using fifth- to sixth-grade reading level with pictures and teach-back methods may 
help patients feel better prepared for discharge and to care for themselves (Parr, 
2017). 
• Consider referral for group psychoeducation for patients with diagnosed mental 
illness. 
• Structured educational sessions and follow up calls (Boucher et al., 2015).  
• Ensure patient understands the benefits of adherence and harms of nonadherence, 
involve support system, encourage routines, adherence instruments such as electronic 
devices, and reminder calls (CDC, 2017a).  
• Use blister packs, pill boxes/containers separated by day of week and time of day, 
request packaging and instructions with large font, provide instructions with large 
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font in layman's terms at reading level fifth-grade or lower (CDC, 2017a; ONS, 
2016). 
• Explore ways to provide medications immediately to patients when prescribed, 
especially for those with psychiatric diagnoses (Tomko et al., 2013).  
• Early follow up with medication reconciliation important (Patel et al., 2017). 
• Surveillance for patients at risk to catch missed follow up appointments. 
      
Conceptual Framework/Model  
 
 The Iowa Model (2015) provides the conceptual framework and direction for this project. 
This model blends principles of frameworks including Transforming Care at the Bedside, 
Transtheoretical Model, and Institute of Medicine (Hall & Roussel, 2014). The Iowa Model 
provides a practical step-by-step guide for implementation of evidence-based projects from 
identifying the trigger to disseminating the results. Working in a multidisciplinary clinic with 
oncologists, advanced practice providers, and a large team of support personnel requires 
consideration of the complexities of cancer care and thoughtful integration of any change into 
practice, so that it is completed in an organized format (Hall & Roussel, 2014). The Iowa Model 
framework provided the framework, and more specifically, provided direction when a 
comprehensive instrument to screen for all of the primary barriers was not found. 
This project utilized the Iowa Model (2015) identification of triggering issues and 
opportunities to guide the project towards creation of an evidence-based instrument. As 
evidenced by the literature discussed earlier, these triggering issues and opportunities are well-
validated. As directed by the Iowa Model, a pilot study became the focus of this project and 
creation of the instrument resulted. The instrument was studied in part to see if a practice change 
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might be beneficial and feasible in the oncology clinic setting. It was decided to test the 
instrument on retrospective data to help determine whether the instrument will work as desired, 
to identify patients who are at increased risk for uncontrolled illness, emergency room visits, and 
hospitalization. After the data was collected, and statistics were completed, the final steps in the 
Iowa Model (2015) help to determine if a change is appropriate for adoption into practice. 
Results show that this is in fact a feasible screening method, so next steps are to begin integrating 
and sustaining the practice change and further refining the instrument. The instrument is the first 
of three parts to addressing nonadherence (as mentioned previously), so in addition to 
implementation, steps will need to be taken to help develop action plans for addressing each 
barrier and tailoring interventions to the patient to aide in adherence.   
Identifying issues such as the impact of medication nonadherence and the impact on the 
clinic, accrediting agency requirements, and philosophy of care guided by the oncology 
organizations such as ASCO and ONS guided the researcher to consider all of the implications of 
a proposed research study. As a part of the process of working through the Iowa Model, there are 
built in fail-safes to appropriately re-route the project and the efforts should it be needed. The 
researcher must ensure that effort going into any project is a priority for the institution, that there 
is sufficient evidence to conduct the project, and that the evidence will lead to an appropriate 
change in practice. In addition to development of the instrument, a team is formed consisting of 
OCM personnel, in particular the navigator who will be one of the primary individuals utilizing 
the instrument should it be evidenced that it has significant usefulness.  
The Iowa Model encourages, and accounts for, the interdisciplinary approach needed to 
implement an evidence-based practice change. Interdisciplinary teamwork is a natural element of 
cancer care which includes involvement of patients in the process, as seen in the Iowa Model 
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revised June of 2015 (The Iowa Model Collaborative, 2017). The Iowa Model guides the 
application of research to practice promoting increased quality of care (Mateo & Foreman, 
2014). 
Theoretical Framework 
 
Theory of transitions. Theory of transitions provides the theoretical framework for this 
project. Dr. Afaf Ibrahim Meleis’ theory of transitions provides a theoretical framework that 
helps identify possible root causes for variables in expected behaviors, relationship among the 
variables, and a framework for examining the outcomes (Im, 2013). Transitions occur when 
people go through various stages and situations in life. These stages include developmental (e.g., 
adolescence to adulthood), situational (e.g., getting married or moving to a new neighborhood), 
health/illness (e.g., diagnoses of cancer), and/or organizational types of changes (e.g., promotion 
at work or taking on a new responsibility in the church) (Im, 2013). In addition to the change 
itself, there are factors that can also influence how the person is impacted by the change such as 
multiple changes at one time, the point in one’s life that the change occurs, or the awareness and 
time span over which the change occurs (Im, 2013). The theory described by Im (2013) helps 
explain why some people go through change well and others do not. The theory of transitions 
may be very useful when examining the variables and their relationship to the ability of a person 
to successfully transition to a state of accepting and successfully managing their disease(s).  
Meleis began developing the theory of transition in the 1970s as she studied immigrant 
populations and their health. The theory was developed from a borrowed sociology theory called 
“Role Insufficiency Theory” (Im, 2013, p. 254). Meleis saw that immigrants often neglected 
preventive health measures, such as preventive health screenings, due to lack of connection to 
their surrounding new community. Immigrants often neglected health problems due to language 
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barriers as well. In addition, they were often away from family and others that would normally 
support them to seek healthcare. Role supplementation is one aspect of the role insufficiency 
theory that Meleis stated can be provided by nurses. Nurses can play a role and step in 
(supplement) where needed to provide education, support, and specific nursing interventions. 
Meleis stated that the goal of healthy transition is “...the mastery of behaviors, sentiments, cues, 
symbols associated with new roles and identities and nonproblematic processes” (as cited in Im, 
2013, p. 255). 
In the adult outpatient cancer clinic, individuals seeking cancer treatment come from all 
walks of life, varying social circumstances, accompanying health conditions and behaviors, and a 
wide range of accompanying cultural beliefs, attitudes, preparation, and knowledge. These are 
known in this theory as transition conditions that can facilitate or inhibit transition during illness 
(Im, 2013). Adherence to medication regimens, especially for those with cancer and 
accompanying comorbidities, are especially at risk if they cannot successfully transition to a state 
of successful adherence to the oncologists prescribed treatment regimen.  
This theory will be helpful to inform why some patients may have a more difficult time 
adjusting to a needed change, no matter how beneficial it might be. Nurses, especially nurses 
practicing at an advanced level, can help patients transition by assessing a person’s readiness, 
educating patients to help prepare and guide them, and providing role supplementation. Coaching 
significant others is also an important skill of the advanced practitioner to guide them in role 
supplementation when necessary to aid in transition from wellness, to a journey through illness 
and either back to wellness, or to a new state of normal again (Meleis, 1975).  
The Doctor of Nursing Practice (DNP) role is in a unique position to use the concepts of 
this theory to inform an evidence-based project for the purpose of aiding patients to successfully 
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transition to a state of medication adherence. In as much, this will help address one of the most 
impactful challenges by those experiencing a new or existing cancer diagnosis. Recognizing and 
appropriately addressing the various factors that play into a person’s successful transition to a 
state of adherence from nonadherence is imperative for ensuring success of the project.  
Summary  
 
Implementation of an evidence-based screening instrument. There were no 
instruments found in literature to assess for presence of the most common, impactful potential 
barriers in a single, comprehensive format. As patients are moved quickly through a clinic 
setting, this inability to efficiently screen for barriers and funnel to available resources such as 
navigators, negatively impacts likelihood of adherence to prescribed medications in complex 
patients with multiple comorbidities. Referral to healthcare personnel for intervention is key to 
the success of the use of this instrument. The search for an organized referral method to ensure 
that patients at high risk of uncontrolled illness and resultant adverse events such as 
rehospitalizations, are provided with maximum available support services is not new or unusual. 
A large healthcare organization in North Carolina is conducting a large study in 40 inpatient 
units with a similar purpose (Duncan et al., 2017). Patients discharged home with stroke are 
enrolled in a COMPASS Care plan that includes referral to a nurse who makes a phone call 
within two days of discharge and sees the patient within two weeks. During the phone and in-
person visit, the patient is assessed for social and functional determinants of health and provided 
with an individualized care plan that includes utilizing community resources and planned follow 
up. A secondary outcome of this study is medication adherence. The authors cited CMS as an 
indication for devising better follow-up care of hospitalized patients. The study is ongoing 
currently (Duncan et al., 2017). As posited earlier, an instrument to help healthcare workers to 
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discover the full gamut and complexity of the barriers to adherence is essential before moving 
forward with interventions. 
 To create an instrument that is as efficient and effective as possible at discovering 
barriers, a multitude of evidence from research was used to organize the instrument into major 
categories of barriers with warning signs to make assessment as efficient as possible. The 
evidence was divided into similar categories, for identifying similar problems. There is some 
slight overlap in some of the categories, and again, this only illustrates some of the complexity of 
this task. In addition to categorizing barriers in an evidence-based fashion, accompanying 
recommendations were added to help address each of the categories of barriers. The result is an 
instrument with five categories of major adherence barriers found in the literature to be the most 
commonly reported, most potentially impactful, and most feasibly actionable. Potential warning 
signs of each of the barriers are listed to help alert healthcare personnel to further evaluate for a 
barrier. This could be likened to symptom alerts for various medical conditions in that some 
symptoms may occur with a variety of problems, but when further evaluated, a disease or 
condition can be pinpointed and treated.  
When combined with a robust patient navigator program and a variety of referral 
resources, the screening instrument will assist healthcare personnel to refer patients for follow up 
and intervention for their adherence barriers. The key to the effectiveness of this instrument as 
supported by literature, is the mechanism for comprehensively identifying multiple, complex, 
intertwining barriers and referring the patients to a navigator to coordinate needed interventions. 
The desired result is to increase adherence, lower incidence of uncontrolled illness, and avoid 
adverse events requiring emergency room visits and hospitalizations.  
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SECTION THREE: METHODOLOGY  
Design  
 
This study was an evidence-based practice study utilizing the Iowa Model for Evidence-
Based Practice. The Iowa Model guides the researcher to design and pilot a practice change 
when sufficient evidence is available. Otherwise it directs to test a change in practice with a pilot 
study (Iowa Model Collaborative, 2017). Due to inability to locate a comprehensive instrument 
containing all of the major barriers identified in the literature, an instrument was developed using 
the evidence found and a study conducted. The pilot study design was a retrospective, quasi-
experimental, observational comparison study to evaluate the validity of a new evidence-based 
screening instrument. Identification of barriers, interventions or potential interventions, and 
ramifications such as uncontrolled illness, unplanned clinic visits, or emergency room visits, or 
hospitalizations, were evaluated on the select group of patients. Patient data was evaluated to 
determine what barriers were identified and if referrals were made using current methods. Next, 
the instrument was applied to evaluate the same patients in this population to see if additional 
barriers listed in the screening instrument were identified. Of those who had barriers according to 
both the current and the new screening methods, there was an evaluation of sensitivity of the 
screening methods by calculating the percentage of those patients who had uncontrolled illness 
and/or events that might have been preventable. 
The qualified CMS OCM patient population was chosen through a report run using 
eligibility criteria described in setting and population. The identified population was further 
analyzed for evidence-based warning signs of potential medication nonadherence using the new 
evidence-based instrument. Within the subset of patients identified to have warning signs, it was 
noted how many were referred to oncology support services for any of the existing applicable 
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adherence warning signs such as depression, distress, or financial issues (following the initial 
financial counseling appointment recommended to all newly diagnosed cancer patients).  
There is future potential to also evaluate specificity of the instrument. Due to the 
retrospective nature of this study, it was not possible to assess accurately for specificity, because 
it was not the practice to assess and record every data point in the instrument. This was not 
unexpected, because there was no formal process for collecting each one of the specific data 
points in the instrument as it does not currently exist. False negatives in this study (patients who 
had uncontrolled illness, but no barrier found in the medical record) could be attributed to the 
fact that patients may have had barriers that simply were not detectable in the retrospective data. 
Therefore, the primary objective in the data analysis following data collection, was to evaluate 
the instrument for sensitivity alone, and note the limitations of the study for specificity. This 
knowledge will be useful in discussion of the follow-up results as it relates to the risk for 
uncontrolled illness and possibly increase in unplanned clinic visits, emergency room visits, and 
hospitalizations or rehospitalizations.  
At the time of the study, the clinic providing the retrospective data did not use a 
screening instrument designed to assess for medication adherence, risks, barriers, uncontrolled 
illness, adverse events, or otherwise. However, each patient prescribed chemotherapy treatment 
was seen at least once for insurance and financial benefits investigation, and regularly screened 
for depression using common depression and distress instruments. This researcher wanted to 
evaluate if the more comprehensive screening instrument developed from literature for this study 
would be more effective in identifying patients at risk for uncontrolled illness or if these existing 
screening instruments could be coincidentally just as adequate. The dependent variable is 
number of patients identified with barriers to medication adherence. Independent variables 
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include previous identification of risk using depression and distress screening instruments alone 
versus the new evidence-based toolkit containing five categorized barriers that include the scores 
obtained on the current depression and distress screening instruments. The additional important 
aspect of this study was to ensure good sensitivity of the new instrument. This was tested by 
determining how many patients identified also had uncontrolled illness. An extra measure was 
used in data evaluation to discover which barrier categories identified in this research had the 
greatest impact on patients with uncontrolled illness.    
Measurable Outcomes  
 
Measurable outcome 1. A statistically significant increase in percentage of prevalence 
of high-risk CMS OCM patients identified with potential actionable barriers to medication 
adherence using the W-BMA screen compared to current screening methods alone.  
Measurable outcome 2. Instrument sensitivity: Patients who are identified to be at risk 
due to barriers found during W-BMA screening will have a significant incidence of uncontrolled 
illness, making use of the instrument to help prevent uncontrolled illness and resulting risk of 
adverse events worthwhile to the organization.   
Setting  
 
The retrospective data used for this study was from a local oncology clinic in Virginia. At 
the time of the study, the clinic was involved in implementation of a system to become compliant 
with new CMS standards related to the IOM’s 13 standards included in their report, Delivering 
High-Quality Cancer Care: Charting a New Course for a System in Crisis (Institute of Medicine, 
2013). This researcher discussed the study with some key stakeholders at the cancer center. The 
consensus of leaders approached about this research topic was that it complemented the goals 
and objectives that were currently in place to comply with the new quality standards for cancer 
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care. The providers of the clinic were aware of the CMS OCM initiatives and the complexity of 
meeting the goals. The key stakeholders at this clinic were seeking methods to address issues 
such as medication adherence and decreasing emergency room visits and hospitalizations for 
CMS OCM patients. They were very open to working with individuals, such as this researcher, 
who might offer help and support. There was brief, yet crucial input provided by clinic staff to 
help determine most appropriate population and population subset for this study. Clinic staff 
assisted with providing the list of patients who met the criteria as well. The real time investment 
will occur during possible future implementation and study of the W-BMA instrument; however, 
the clinic has invested in a CMS OCM nurse navigator who is available to help support 
implementation of the screening instrument, and to embrace a change that would help them 
provide better care, improve quality scores, and decrease costs.  
Population  
 
This retrospective review of data included CMS patients enrolled in the OCM program at 
a standalone community cancer center in Virginia. Located within two blocks, the community is 
also served by an approximately 300-bed hospital which is designated a level-two trauma center 
and part of a multi-facility healthcare system. At the time of this study, the two-story cancer 
center contained an eight-physician medical oncology practice, infusion center, and clinical 
research department on one floor, and on the other, a three-physician radiation oncology practice. 
Administrative support services located in the cancer center included an oncology nurse 
navigator team, social workers, dietician, nurse educator, and genetic counselor.  
The cancer center participated in interdisciplinary comprehensive cancer conferences and 
tumor board meetings and had been awarded quality program recognitions for oncology care and 
various other programs for several years in a row. Patients enrolled in the OCM program at the 
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cancer center are generally at least 65 years of age or older and have received cancer treatment 
within the last 6 months. Patients over 65, especially those with multiple comorbidities, receiving 
chemotherapy treatment are at increased risk for adverse health outcomes when nonadherent to 
their treatment regimen (Sarfati et al., 2016). The qualified CMS OCM patient population was 
chosen because of their vulnerability to adverse health outcomes and need for improved 
medication adherence screening barriers.  
Inclusion to the study required that patients had at least two visits within the previous 
year, and that they were enrolled in the OCM program which indicates that they were Medicare 
recipients and had received chemotherapy treatment. The sample was selected via a report 
identifying those patients who were enrolled in the OCM program and had multiple visits within 
the retrospective time frame. The researcher’s previous experience working with this patient 
population, as well as the vulnerability of this population to adverse events from nonadherence, 
combined with a setting in which the stakeholders are open to development and implementation 
of a screening instrument, made this the ideal setting and population for this study. 
There were 759 patients enrolled in the OCM program at the time of the random selection 
for the study making up the population of focus for this research. The researcher requested that 
the administrative personnel collecting the sample for the study select every third patient to 
ensure a systematic sampling of the population. This sample was provided in the form of a list 
which was kept locked to ensure privacy. The population sample studied included 250 OCM 
patients treated and seen at the clinic at least twice in the previous year. Most of the population 
was born between 1934 and 1950 with a mean, median, and mode of 1944. English was the 
primary language spoken by almost 99% of the sample that included 119 male patients and 131 
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females. The average number of prescribed medications in this sample was 10 with 10% taking 
over 20 medications each.  
The profile of a typical subject of this research, based on evaluation of findings, can be 
described as a 74-year-old English-speaking woman living on social security with Medicare 
insurance. She has been diagnosed with cancer within the last year and had chemotherapy 
treatments, which may have been ongoing. She must return to the oncology office on a regular 
basis for treatment and/or evaluation of adverse effects of the chemotherapy treatment and have 
lab and radiology tests to evaluate for treatment effectiveness and recurrence of the cancer. In 
addition to her cancer diagnoses, she has multiple comorbidities including DM-2, and HTN 
which require that she see her general practitioner and possibly another specialist on a regular 
basis. She has been prescribed about 10 medications that she must take on a daily or prn basis. 
This number does not include any chemotherapy (intravenous or oral) or medications given in 
conjunction with the chemotherapy to prevent adverse reactions or immediate side effects. 
Neither does this number account for over-the-counter medications such as allergy or cold 
remedies, sleep aides, pain relievers, vitamins, or herbal supplements. Her medication list that 
she provides to the oncologist does not match what she provides to healthcare personnel as an 
inpatient. She lives with her spouse and has a less-than-ideal physical status (ECOG 1) spending 
a majority of the day sitting down or in bed due to not feeling well. Her blood glucoses are 
typically elevated at each clinic visit. Multiple consecutive elevated blood pressure readings 
indicate she may have uncontrolled stage two hypertension.  
Ethical Considerations  
 
Completion of Collaborative Institutional Training Initiative required training for 
protection of human subjects (see Appendix C) by both the study chair and the researcher helped 
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to ensure that ethical standards were upheld in the conduct of the research. The study was 
approved by both the Institutional Review Boards (IRBs) of the university and the healthcare 
institution. In addition, the study was reviewed by the Nursing Research Council of the 
healthcare institution. A copy of approval letters are included in the appendices (see Appendix 
F). As this is a retrospective chart review with collection of only de-identified data that cannot be 
traced back to any individual patient and obtaining consent would create the only identifiable 
attachment to the study, no consent was required. Although data will be de-identified, the key 
and all sensitive patient information was kept secure in a locked office and/or on a secure 
electronic file requiring a password and will be destroyed following completion of all research 
surrounding this instrument.   
Data Collection 
 
The historical medical records of 250 OCM patients were reviewed one at a time using 
the data collection instrument coded for use with the Statistical Package for the Social Sciences 
(SPSS) analysis. This researcher extracted, recorded, and coded the data for this study. A data 
collection sheet was used for each individual patient and later entered into SPSS. Two separate 
electronic medical records (EMRs) were in existence at the time of the study. To ensure that all 
applicable data was included, both EMRs were thoroughly reviewed.  
After the patient identification code was transcribed to the data collection sheet, a note 
was made of the patient’s year of birth and gender. Data was first reviewed for the presence of 
PHQ-9 depression screen score of 15 or higher and an NCCN Distress score of 4 or higher. 
Following that, it was noted if any interventions took place for the screening scores. This data 
was recorded on the data collection sheet.  
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Following a review of current screening methods, the researcher then analyzed the patient 
record to extract warning signs as listed in the W-BMA screening instrument. The W-BMA 
screening instrument includes the depression and distress screening results as part of the 
comprehensive review of risk. Any warning sign found in the record resulted in a positive screen 
for the category in which it applied. Also noted and recorded were applicable interventions, signs 
and symptoms of uncontrolled illness, and unplanned healthcare visits. The primary purpose for 
collecting the data in this manner was to collect the data needed to evaluate the desired 
measurable outcomes for this study. First, to see if there was an increase in percentage of patients 
identified with actionable barriers to medication adherence compared to those identified in 
current screening methods alone. Second, to see if there is instrument sensitivity as predicted. 
The secondary purpose for collecting this data in this manner was to evaluate the W-BMA 
screening tool for future refinement and to learn from any incidental findings. SPSS coding was 
performed as specified in Appendix G. 
Instruments  
 
An extensive search did not reveal an instrument that would efficiently and effectively 
identify all the major barriers to adherence found in the literature review in an organized way. As 
a result, this study became an evidence-based pilot study to evaluate an instrument that would 
fulfill this purpose. To create an instrument that would be as efficient and effective as possible, 
an extensive review of evidence from research was organized into major categories of barriers 
with warning signs. The evidence was divided into similar categories with well-documented 
research addressing each category. Over 40 barriers were identified; however, many of these 
could be classified into a major barrier such as financial or medical. As a result, five major 
barrier classifications with warning signs were developed, along with recommended strategies 
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for addressing each category according to the literature found. The result is an instrument with 
five categories of major adherence barriers found in the literature to be the most commonly 
reported, most potentially impactful, and most feasibly actionable determined by the review of 
literature and experience. Experience is an expected component of evidence-based practice but 
was used cautiously in this study. Potential warning signs of each of the barriers are listed to help 
alert healthcare personnel to a potential barrier. The literature review contains a detailed 
description of the evidence used to support each of the five categories of barriers. The categories 
of the W-BMA include Financial/Social Support, Depression/Distress/Anxiety, Medical Related, 
Behavior/Lifestyle, and Education. The W-BMA was prepared with future dissemination in mind 
and includes talking points and review of literature for each category for quick reference. See 
Appendix D for the full four-page instrument. The basic W-BMA (Washburn_Barrier to 
Medication Adherence Risk Assessment) Screening Instrument developed for data collection for 
this study is pictured in Figure 1 on the next page.   
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Barrier: Warning Signs: Notes: 
(referrals/interventions) 
  Financial/Social 
Support 
o Age 65 or higher and one or more of the 
following: 
o Unmarried and/or absence of social support  
o Medicaid eligible 
o Income less than 50,000 dollars/year 
o Limited pharmacy access (location of 
residence related to pharmacy, resides 
outside of city, lack of transportation) 
 
  Depression/ 
Distress/ 
Anxiety 
o PHQ-9 Depression screen Score of 15 or 
higher 
o NCCN Distress Score of 4 or higher 
o Diagnoses of anxiety, or on medication for 
anxiety 
 
  Medical Related 
Concerns 
 
Related cues:  Side 
effects/Effectiveness/Medica
tion Reconciliation 
Issues/relationship with 
provider/multiple 
comorbidities/ 
Polypharmacy/ Poor 
Performance Score 
(ECOG)/cancer therapy last 
6 months 
o More than 10 medications 
o Uncontrolled illness  
o Unexpected side effects and/or lack of 
expected side effects  
o Distressed about side effects 
o Prescription not filled or refilled at expected 
rate  
o Late stage of cancer 
o Poor physical status (ECOG 1 or over) 
o Provider relationship strained  
o No show for appointments and reluctance to 
reschedule/Requesting a different provider  
o Significant other concerns about not 
following treatment regimen 
Record # of meds 
here:______ 
  Behavior/Lifestyle  
 
 Related cues: 
Forgetting/Don't think it's 
needed/Didn't "agree" to 
take it/Don't like taking it/ 
too busy/Away from 
home/no established routine 
o Prescription not refilled at expected 
intervals 
o Pill bottle contains more pills than it should 
based on fill date (If it is the original bottle) 
o Taking additional unprescribed herbal or 
"natural" substances 
o Tobacco, ETOH abuse, illegal drug use 
o Weekly/daily pill box contains 
unopened/unused pills 
o Reluctance to accept a change in regimen 
o Preference to be "prescription free" or "all 
natural" or other alternatives 
 
  Educational 
  
Related cues: Knowledge 
deficits including general 
knowledge/limited English 
proficiency/functional/Cogn
itive/Psychological/Health 
literacy/Vision 
Impairment/Hard of 
Hearing/Memory 
impairment/misconceptions 
/Distrust 
o English is not first language 
o Reluctance, difficulty, or inability to read 
and/or correctly explain written medication 
instructions (on pill bottle or med list) 
o Medication not taken correctly 
o Identifies medications by color, size, and 
shape but unable to explain what 
medications are, or what they are for.  
o Has not filled prescription/reluctant to 
answer questions about compliance with 
regimen 
o Significant other takes care of all paperwork 
o Known memory impairment 
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Uncontrolled Chronic 
Illness: 
Signs/Symptoms: Related Medication if 
applicable:  
  Diabetes  
 
 
 
  Hypertension/
CVD 
 
 
 
 
  Renal 
Impairment 
 
 
 
 
  Sustained 
uncontrolled 
depression or 
Mental Illness  
 
 
 
  COPD/ 
Asthma 
 
 
 
 
Unplanned Care:                                     Sign/Symptom/Diagnoses Related medication if 
applicable 
  Clinic Visit   
  Emergency 
Room Visit 
  
  Hospitalization   
Note if support services were involved throughout the retrospective service dates  yes/no 
 Figure 1. Washburn_Barrier to Medication Adherence Screening Instrument. Copyright 2018 
The W-BMA instrument, along with the methods for data collection and data analysis 
were reviewed by both university and healthcare IRBs as part of the study approval process and 
approved for data collection for this study. For data analysis of the first outcome, the information 
was grouped into one dependent variable—number of patients detected by the instruments in 
question, and two independent variables—number of patients with high depression and/or 
distress score known as current screen and number of patients with at least one of the five 
barriers known as W-BMA instrument or W-BMA screen. For data analysis of the second 
outcome, any one or more types of incidences of uncontrolled illness was recorded as an event 
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for sensitivity and specificity tests. Although there were no expectations that all warning signs 
would be evident in the process of data collection, the education barrier category and clinic visit 
category were both difficult to assess with confidence. However, even though there was not 
enough evidence to factor these into data collection, leaving education in the barrier assessment 
category is supported by literature and leaving clinic visits in the assessment for adverse events 
may be useful for future testing of financial impact.  
Intervention 
 
An extensive, comprehensive literature review was completed in 2017 and early 2018 
followed by development of the W-BMA instrument. The healthcare professionals assigned to 
work with OCM patients were consulted for feasibility input and to discuss a method of 
collecting a systematic patient sample. IRB approval was requested in late March and obtained in 
June 2018. Data collection was immediately started, following obtaining the list of sample 
patients from the quality coordinator. The qualified CMS OCM patient population was 
identified, and the retrospective chart review completed at the end of July 2018. The data 
extracted from the record was coded and entered into SPSS. A statistician was consulted in mid-
August, and in mid-September of 2018 analysis was completed which then allowed for recording 
of the results of the retrospective study in this paper.   
Feasibility Analysis 
 
This study was feasible in that it required very limited initial resource of time, not more 
than one hour from two specific healthcare personnel dedicated to this population to provide 
input into instrument feasibility as well as the patient sample list. Approximately half a ream of 
paper was utilized for 250 printed data collection instruments. The time needed to conduct the 
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study fit within the available dedicated DNP practicum time of the researcher, thus no salary was 
required for the majority of work done on the study. 
Data Analysis  
 
The Iowa Model Collaborative (2017) directs to use a pilot study when implementing 
evidence into practice. This plus using retrospective data, was important when testing the 
validity of this newly developed instrument. This pilot evidence-based practice research study 
included a systematically chosen sample of OCM patients and examination of retrospective data 
from their records for up to one year before IRB approval between June 1st, 2017 and May 31st, 
2018. This research focused on two measurable outcomes to pilot an evaluation of the validity of 
the W-BMA instrument. This instrument was compared to existing screening methods alone to 
rule out the possibility that it is as effective in identifying patients at risk for nonadherence and 
resulting uncontrolled illness. All statistical analysis on this data was completed using IBM SPSS 
Statistics for windows vs. 25 (IBM Corp, 2017). The sample was chosen to ensure a 95% to 99% 
confidence interval with 1% to 5% margin of error. Specific tests were performed to evaluate 
each outcome; however, a statistician was consulted, and a classification tree recommended to 
assess independent variables that were the most impactful in patients with uncontrolled illness as 
found in the retrospective data. The classification tree was useful in incorporating the intent of 
this screening instrument into a visual useful in ongoing evaluations, and possible future 
development of a guide to prioritization of barrier interventions.  
For SPSS analysis purposes, the researcher coded data as described in Appendix G. Data 
was grouped and coded to transform data into dichotomous output and entered into SPSS in 
separate variable fields used to perform the statistical tests. The uncontrolled event fields were 
recorded as either yes (1) there was an uncontrolled illness of some type, or no (2) there was no 
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uncontrolled illness found for that patient. The data used specifically for each measurable 
outcome was coded in a similar fashion as described below. This provided simple nominal data 
for use with the statistical tests.   
Measurable outcome 1. The first measurable outcome of interest was to evaluate 
whether there was a statistically significant increase in percentage of prevalence of high-risk 
CMS OCM patients identified with potential actionable barriers to medication adherence 
compared to current screening methods alone. Data collected on the current screening 
instruments was coded to indicate the result, whether the screen was found to be positive or 
negative for a risk factor. If either the current depression and/or distress screening instruments 
was found to be abnormal, this was recorded as a positive result for the independent variable of 
current screening methods. Yes (1) if positive and if within normal range, a no (2) for negative 
was recorded for that variable. The same method was carried out with the second independent 
variable, the W-BMA screening instrument. The patients’ records were further evaluated for all 
five categories of risk, and if there was at least one barrier found, it was recorded as a positive 
finding. If any one of the five major barrier categories were marked as positive (meaning 
warning signs of a barrier existed) the variable was marked yes (1) or if none were found it was 
marked no (2) for negative.  
The hypothesis was that the W-BMA screen would identify more people at risk for 
nonadherence than the current screening method alone. To evaluate the data, a paired T-test was 
planned first to compare the population before and after application of the new screening 
instrument. A paired T-test is used for comparison when two different methods of measurement 
are applied to the same subjects (Mathematics Learning Support Centre, n.d.). Although a T-test 
might be used due to the nominal or dichotomous variables (Sullivan, 2017).  The test was not 
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appropriate here partially due to the distribution of data before and after the instrument was 
applied. A normal distribution is required for accurate results in this test. To evaluate whether the 
results disproved the null hypothesis that the current depression and distress screening method 
will be as effective in identifying patients at risk for nonadherence as the new screening 
instrument, a simple frequencies table was produced in SPSS.    
Measurable outcome 2. Instrument sensitivity: The hypothesis of this outcome is that 
patients who are identified to be at risk due to barriers found during retrospective screening will 
also have a significant incidence of uncontrolled illness. As a result, it is hoped that investing the 
time to use the W-BMA instrument to proactively help prevent uncontrolled illness and resulting 
risk of adverse events will be worthwhile to the organization. Sullivan (2017) states that 
screening tests are not for the purpose of making a medical diagnoses. They are intended to 
identify individuals most at risk.  
Although sensitivity testing was easily applied to these study results, specificity was 
evaluated, but not significant in this study because of the retrospective nature of the study. False 
negatives (patients who had uncontrolled illness and/or adverse events but no identified barriers) 
in this study could be attributed to the fact that patients may have had barriers that simply were 
not detectable in the retrospective data. Further research is needed to evaluate instrument 
specificity.  
SECTION FOUR: RESULTS  
Descriptive Statistics 
 
This was a retrospective, quasi-experimental, observational, comparison pilot study using 
three statistical tests on dichotomous data. A sample of 250 out of a population of 759 patients 
was systematically selected for improved probability sampling. Frequencies run in SPSS 
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provided information on difference between the number of patients identified with potential 
actionable barriers to medication adherence using the W-BMA screen (97.6%  [86.0%  with 
associated medication]) compared to current screening methods alone (28.4%). 
Next, a sensitivity and specificity tests were analyzed for the second hypothesis to 
evaluate if the instrument was correctly identifying patients at risk for uncontrolled illness. 
Patients with any identified risk factors were evaluated for uncontrolled illness. In previous 
discussion, it was established that specificity testing was not feasible for this retrospective data. 
Sensitivity test resulted in 83.2% of patients identified with barriers had an uncontrolled illness 
and 86.2% of patients with barriers had uncontrolled illness related to a prescribed medication.  
Classification tree results were as follows: 184 out of 250 (73.6%) of W-BMA screened 
patients had uncontrolled illness or events consisting of extra clinic visits, emergency room 
visits, or hospitalizations. Of those patients, 82.8% had barriers in the category of medical related 
concerns undetected with current screen methods and had uncontrolled illness. For those patients 
either without barriers, or whose medical related barriers were fully addressed by a healthcare 
worker, 34% had uncontrolled illness. The Chi-square test imbedded in the classification tree 
results is indicative that the variables are in fact dependent.  
Of interest, notice again the less-than-ideal specificity, indicated below in Figure 2, 
probably primarily due to use of retrospective data.  The W-BMA instrument includes warning 
signs that are not always historically recorded, so where W-BMA results were negative for 
barriers, there may in fact be a barrier leading to the uncontrolled illness. This is where 
additional study of the W-BMA instrument may be beneficial. In patients where the W-BMA 
instrument identified behavior and lifestyle concerns undetected by current screening, 80% (P < 
.0009) of those individuals had uncontrolled illness or events. 
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Figure 2. Classification tree: Patients with uncontrolled illness or event(s). 
To further evaluate the impact of barriers found by the W-BMA instrument, over half 
(56.6%) of the time, uncontrolled illness was found in patients prescribed a medication for their 
illness. Of those patients for which medication was prescribed, 62.0% (P < .0002) had undetected 
medical related barriers using current screening methods. These patients had incidence of 
uncontrolled illness, despite having a medication prescribed for that illness. From the original 
(56.6%) group of patients with uncontrolled illness related to medication prescriptions, 29.0% (P 
< .0002) of those individuals had barriers detected and addressed, yet still had incidence of 
uncontrolled illness. These patients also had behavior and lifestyle concerns which went 
undetected in four out of nine patients resulting in an 80.0% incidence of uncontrolled illness 
when not detected and addressed.  
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Figure 3. Classification tree: Patients with uncontrolled illness or event(s) and related prescribed 
medication. 
The data in the classification trees described above contains some very positive 
information of note. In several cases, the data shows the impact made by the oncology healthcare 
staff. When oncology service nurse navigators, social workers, or others intervened to address 
barriers, there was a clear reduction in uncontrolled illness or events. For example, in the first 
classification tree, Figure 2, when medical or behavior/lifestyle concerns were detected and 
addressed by these individuals, there was no uncontrolled illness or events 66.0% and 100.0% of 
the time respectively. Likewise, in the second classification tree, Figure 3, for the same barriers, 
patients with related medications who maintained controlled and out of the emergency room and 
hospital were 71.0% and approximately 80.8% respectively.  
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SECTION FIVE: DISCUSSION  
Implication for Practice 
 
Currently there are many published toolkits available for use in healthcare settings. In 
addition, one can search literature and find a multitude of research on barriers to adherence, and 
interventions proven to have an impact on adherence and illness control. However, what is not 
found, is a comprehensive evidence-based instrument to screen for the most common, impactful 
barriers to medication adherence. Introducing the use of a comprehensive risk assessment tool 
such as the W-BMA instrument into practice is a first step in developing a comprehensive 
program to remove medication adherence barriers. Removing barriers to medication adherence 
may result in better controlled illness and reduced healthcare costs.  
This research study included a pilot, or test-run, of the W-BMA screening instrument in 
retrospective data of OCM cancer patients. Despite the use of retrospective data, the new 
evidence-based instrument was found to be a more sensitive detector of potentially impactful and 
actionable barriers than the combined use of the PHQ-9 depression and NCCN distress screening 
instruments alone. This was an important question to answer, because although depression and 
distress impact many facets of a person’s life, nonadherence can be complex, multifaceted, and 
require intervention of more than one form. Healthcare professionals may have erroneous 
notions that nonadherence is rare, misunderstand the barriers that make a patient nonadherent, 
and misunderstand the typical profile of a nonadherent patient. This may result in overlooking 
many nonadherent patients daily.  
One lesson learned in this research involved observation of a high percentage of patients 
with uncontrolled illness. Nonadherence to medication regimens due primarily to the barriers 
listed in the screening tool may be a primary reason for these observances. Any question about 
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how common nonadherence is in the general population can be answered with the evidence from 
the aforementioned literature estimating that 50% to 70% of prescriptions make it to the 
pharmacy, 48% to 66% come out of a pharmacy, 25% to 30% are taken properly, and only 15% 
to 20% are refilled as prescribed (AMA, 2018; CDC, 2017a; Million Hearts, 2017). The findings 
of this study and incidence of uncontrolled illness in the sample, combined with the evidence 
from literature, creates a strong argument that nonadherence to medication regimens in these 
patients is likely related to the uncontrolled illness. 
The SPSS frequencies analysis was conducted to compare the W-BMA screen with the 
current screens alone. The results suggest that the W-BMA really does identify a significantly 
larger number of patients with barriers than the current screens alone. The null hypothesis 
“Current screening methods alone identify a similar number of “at-risk” patients as the W-BMA 
screening method”, however, the W-BMA screen identified more at-risk patients, allowing 
rejection of this null hypothesis. A significant number of patients in the sample size had barriers 
that went undetected by the healthcare clinic probably due to a lack of screening methods for 
these barriers. The significance of this finding was revealed in the classification tree produced in 
consultation with a statistician. The classification tree and sensitivity test shows evidence that 
first, the barriers found by the W-BMA screening instrument are strongly related to uncontrolled 
illness and second, illustrates how barriers can be complex and multi-layered so that even if one 
barrier is addressed, there may be others that significantly impact adherence and the health of the 
patient.  
The use of retrospective data aided in accomplishing this pilot study without risk to the 
population to which it was applied. This researcher gained valuable insight into the potential use 
of the instrument in practice, especially as part of a disease or population specific intervention 
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program. Patient navigators, social workers, case managers, clinical nurse specialists, nurse 
practitioners, and patient educators working with populations at risk may find benefit in 
implementing this comprehensive screening instrument. The information derived from this pilot 
test did not in itself validate the instrument. Much of the validation has been derived from the 
copious amounts of fine work done by hundreds of individuals to resolve this very complex issue 
as demonstrated in the existing literature. Much of this available literature is outlined in 
Appendix A and discussed in the literature review.  
A benefit of a pilot study is the ability for researchers to make improvements in the 
design of the study through lessons learned. Many ideas look great on paper, but seeing them in 
action allows researchers to gain a realistic perspective and identify the limitations and design 
flaws. This helps ensure success and efficiency of the larger study. Much of the validity of this 
instrument comes from the literature, but validity and feasibility of application of the instrument 
for practice must be assessed as evidence-based practice studies in each unique setting for which 
application is desired. The W-BMA instrument was developed with the structure and resources 
of the local cancer center in mind. The cancer center and associated healthcare system employs 
navigators and other staff who have the expertise and resources to intervene for some of the most 
vulnerable of the population as a part of a comprehensive navigation program. This research did 
not focus specifically on the impact of navigation or social work; however, the results of this 
study, especially as seen in the classification trees, indicate that these services do play an 
important role in promoting the well-being of vulnerable patient populations. Having this 
instrument available as a resource to help detect more impactful barriers may result in a lower 
rate of uncontrolled illness and adverse events. 
Limitations   
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This research study had several limitations, many of those are intrinsic to pilot studies 
involving untested processes or procedures. However, there are those that warrant discussion to 
inform for future research on this instrument and warn those who may be tempted to use the 
instrument in practice without further study. Following are some of the limitations most 
impactful to this research study and worthwhile noting for future research using this instrument. 
One limitation of this study involved the availability of data due to the retrospective 
design. The statistical tests used combined both categories of current, and all five categories of 
the W-BMA screening instruments, into one variable. However, not all warning signs, or even all 
categories of the W-BMA, could be assessed on retrospective data. Many of the individual data 
points in each category are not typically assessed and recorded in a normal clinic setting. This 
limited the ability to test for specificity of the instrument. The education barrier category and 
clinic visit category were both difficult to assess with confidence due to available documentation. 
There were not enough results from those single categories to report any meaningful findings as 
an independent variable. However, leaving education in the barrier assessment category is 
supported by literature and leaving clinic visits in the assessment for adverse events may be 
useful for future testing for financial impact. Prospective studies that include purposeful 
collection of all data points would help provide a robust evaluation of the W-BMA instrument. 
Subject demographics aside from general population information, were limited to gender 
and age. Race was not recorded and is an important consideration in future analysis of this 
instrument. In the population studied, the race most common to the population is known to be 
Caucasian, which mirrors the population treated as a whole at the cancer center. It may be 
beneficial to include race in the demographics of future studies, especially in locations where 
there is a more diverse mix of patient race. Additional demographics may be helpful including 
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income level, zip code, transportation, employment, and specific social support (marital status) 
available to the patient. 
Uncontrolled illness was used to test sensitivity; however, this assumes that the 
uncontrolled illnesses were caused by medication nonadherence or were somehow directly 
related. The classification tree arranges specific W-BMA barriers according to prevalence in the 
subset of patients with uncontrolled illness. However, there may be additional barriers, 
undetected in the data that would be more impactful to the patients’ ability to adhere to their 
medication regimen. A prospective study in which each barrier category is thoroughly assessed 
would help eliminate this limitation. In addition, a prospective study may also help correlate 
medication nonadherence to the barriers and uncontrolled illnesses, although the literature makes 
a strong case to prove a hypothesis of that nature. 
 Another limitation is that the W-BMA instrument is a new screening instrument only 
tested by this single pilot study in a very specific population rife with medical comorbidities. 
Uncontrolled illness in this population may be much more common than in other populations, 
making the sensitivity testing for this group not applicable to other groups of patients. More 
testing is needed to validate the screening instrument in other populations to evaluate 
effectiveness at detecting preventable barriers and improving adherence. As noted in the 
introduction, research shows that people who are already adherent are very likely to stay 
adherent. This helps to conclude that future research may best be focused on populations that 
tend to have difficulty with medication adherence, multiple comorbidities, and uncontrolled 
illness. Although the screening instrument was created from research that proved there is a 
significant association of these barriers to uncontrolled illness, it is still an assumption that likely 
requires further testing.  
ADDRESSING BARRIERS TO ADHERENCE  71 
Finally, the sample was selected in a manner to eliminate sample bias; however, the 
researcher then collected, coded, and entered the data into SPSS. Having an independent person 
code the data for preparation of entry into SPSS is normally recommended to help ensure good 
coding practices are used, and researcher bias is avoided. This researcher hopes to further 
explore the use of this instrument in additional vulnerable populations, avoiding some of the 
limitations discussed here.  
Sustainability 
 
Adherence to a medication regimen is often a complex issue that requires thoughtful 
consideration and sustained intervention at the micro, mezzo, and macro levels. The use of the 
W-BMA screening instrument will be sustained if properly used and integrated into a larger 
comprehensive program. The micro level will be sustained through thoughtful use and 
interpretation of the instrument by the health professionals working with the patient. At the 
mezzo level, the health professional must engage with local, organizational groups such as 
palliative care teams, and resources such as navigators, social work, educators, advanced practice 
nurses, pharmacists, and others to develop a team approach to address barriers for each patient. 
The macro level requires that the entire community become engaged in supporting patients with 
adherence issues on a long-term basis. Examples of community programs that can help sustain 
interventions include community paramedic programs and reduced medication cost programs. 
Sustainability for the W-BMA screening instrument will require that it be used as a part of a 
comprehensive program at all three levels for identification of, and intervention for barriers.  
The environment in which this study took place is a very supportive environment in 
which innovative improvements in practice are encouraged. Healthcare professionals and 
administration work tirelessly to improve the entire oncology populations’ healthcare outcomes 
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and quality of life. The cancer center employs a team of healthcare professionals that include 
disease and population specific navigators, including an OCM navigator, as well as other integral 
support professionals such as social workers and educators. These individuals may utilize the W-
BMA instrument for a full evaluation of patients in this population. Clinic physicians, nurses and 
staff simply do not have the time to complete the full evaluation required for best use of the 
instrument. Any attempt to integrate full screening at this level is not sustainable. However, a 
referral may be quickly made to a navigator when any number of barriers are identified by clinic 
staff. In certain populations, such as the one studied here, patients are automatically referred to a 
navigator at which time the instrument can be fully utilized.  
Attempts to implement the instrument into an EMR for use on a wider patient population 
is something that could be examined in the future after further refining and study. This could be 
implemented in such a way that identification of a warning sign such as uncontrolled illness, or a 
high distress screening score would trigger a referral for further evaluation. Future use of the tool 
may include referral of additional populations of patients in the practice, generated from 
inpatient, or outpatient physicians, nurses and other healthcare professionals by simply 
identifying warning signs in one of the barriers.  
The instrument studied in this project requires additional analysis and refinement before 
full implementation; however, the healthcare professionals involved with the population studied 
are very open to change and adoption of new methods or technology. It appears that addition of 
this screening may enhance the excellent services provided to the patients under their care. The 
key to sustainability for this screening instrument is in the methods used to glean the needed 
information from the patients, and then identifying, prioritizing, and adopting the appropriate 
interventions for each of the barriers found.  
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An important aspect of sustainability is correct use and interpretation of the instrument. 
One must be able to prioritize the barriers with consideration that resolving one barrier may also 
help resolve other dependent barriers, because attempting resolution of a barrier that is dependent 
on resolution of a more impactful barrier could be futile. Such futility would create an illusion of 
instrument ineffectiveness and discourage continued use. Continued use of the instrument may 
be influenced by measurable improvements in adherence to prescribed medications with reduced 
incidence of uncontrolled illness. Healthcare professionals utilizing this instrument will need to 
have access to the resources required, use critical thinking to prioritize the interventions needed, 
and implement them in a way that is sustainable for these patients who often have very complex 
barriers. 
Dissemination Plan  
 
The bible provided much of the inspiration for this researcher when developing and 
researching the W-BMA instrument and planning for dissemination. Isaiah 43:19 states, 
“Behold, I will do a new thing; now it shall spring forth; shall ye not know it? I will even make a 
way in the wilderness, and rivers in the desert” (King James Version). Healthcare professionals’ 
(this researcher included) begin to raise their threshold of what is acceptable in the way of 
nonadherent behavior and uncontrolled illness, as it becomes more and more prevalent. Perhaps 
this happens very slowly over a period of several years in a healthcare system serving patients 
with increasingly complex intertwining factors, including more pressing healthcare issues such 
as cancer. Another contributing factor may also be that comorbid illnesses are often managed by 
multiple, loosely connected healthcare teams.   
After nine years of work in oncology clinical research, this author learned that evaluating 
medication adherence, working closely with all healthcare teams involved in the care of the 
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patient’s comorbid conditions, and intervening to remove barriers to adherence, increases a 
patient’s likelihood of adherence to their medication regimens and lowers their likelihood of 
uncontrolled illness and resulting adverse events. This researcher also observed the effectiveness 
of a navigation program for patients with complex illnesses managed by multiple systems and 
teams. With this background in mind and with support from oncology clinic administration and 
support team, this project was undertaken to develop an instrument that might help improve 
OCM patients’ adherence and lower incidence of uncontrolled illness. Dissemination of the 
knowledge learned in this research will be accompanied by a word of caution that it was a pilot 
project requiring more study, but with great hope that it will eventually improve the health and 
welfare of some of the most vulnerable cancer patients, and eventually other populations as well.  
The Iowa Model provides a practical step-by-step model to guide implementation of evidence-
based projects from identifying the trigger to disseminating the results. Dissemination will take 
place in multiple formats following the Iowa Model “Implementation Strategies for Evidence-
Based Practice” (Cullen & Adams, 2012). 
Although patients are the focus of this evidence-based screening intervention, the target 
of dissemination will be the healthcare professionals and administration who will integrate this 
instrument into a comprehensive medication adherence program for their patient population. 
Methods to disseminate this information will include poster presentations, podium presentations, 
and publication of a manuscript based on this project, preferably to a journal of nursing specific 
to oncology nursing. Organizational support will be guided by the Iowa Implementation Model 
beginning with education about these research findings and recommendations for further 
research on the use of this instrument in a prospective manner. This researcher will also upload 
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this project to Liberty University Scholars Crossing where it can be accessed through the world-
wide web. 
This evidence-based research study invites a plethora of new collaborative research by 
nursing and other healthcare team members. The use of the instrument requires study to further 
assess feasibility of use in busy cancer centers. Can this instrument also be used in at-risk clinics 
for other acute or chronic disease states, or even the patient who returns repeatedly to the 
emergency room for treatment of uncontrolled chronic illness like diabetes? Evidence-based 
practice requires input and agreement from three sources for success: literature, healthcare 
providers, and patients. This study presents a resource that is validated with literature, pilot 
tested in one local population, and now needs to be tested and critiqued by healthcare providers 
in other communities and populations. Patients need to be approached with this screening in a 
manner that encourages open and honest participation, a challenge when working with people 
who often do not feel well and move quickly through their clinic visits.  
In addition, there is a need to evaluate the impact of barriers and prioritization of 
interventions. The research found in this project was very informative for addressing individual 
barriers, but how is this applied to complex patients with multi-layered barriers? As indicated by 
the classification trees, individuals are still at risk when there are underlying issues. How does 
the healthcare community come together to ensure a sustainable practice of identifying these 
vulnerable patients and interceding to remove all impactful barriers, improve adherence, and 
measure resulting impact to the healthcare system? As a healthcare system, effort must be made 
to improve adherence to medication regimens and reduce the incidence of uncontrolled illness in 
our most vulnerable patient populations. 
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“And let us not be weary in well doing for in due season we shall reap, if we faint not.”  
Galatians 6:9 (KJV) 
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Name: Addressing Barriers to Medication Adherence: An Evidence-Based Screening Instrument Validation Study  
Clinical Question: In a one-year retrospective review of CMS eligible outpatient records, does the use of a new evidence-based 
screening instrument developed from literature, compared to current screening methods, increase identification of patients with 
barriers to medication adherence? 
Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Al-Batran, M. 
(2015). 
Evidence based 
practice: The 
effectiveness of 
group 
psychoeducatio
n for 
medications 
adherence 
among inpatient 
adults with 
schizophrenia in 
psychiatric and 
mental health 
settings. Middle 
East Journal of 
Nursing, 9(2), 
25-30. 
Examine 
effectiveness of 
group psycho-
education for 
medication 
adherence in adults 
suffering from 
Schizophrenia 
This is an 
analysis of 
systematic 
reviews and 
randomized 
controlled 
trials focusing 
on the 
effectiveness 
of group 
psychoeducati
on for 
Schizophrenic 
patients. 
Studies were 
selected from 
CINAHL, Pub-
med, and 
MEDLINE from 
the years between 
2009 and 2013 
It was proven that 
group 
psychoeducation for 
medication 
adherence was 
proven effective. 
Rehospitalizations 
were decreased, as 
well as a reduction in 
length of 
hospitalization. It 
also increased quality 
of life, and self-
esteem among other 
things.  
Level 1: 
Systematic 
Review of 
controlled 
trials 
Schizophrenia 
can be very 
challenging, there 
is a high rate of 
drop-out from 
these programs, 
and the education 
cannot change 
certain behaviors. 
In addition, fear 
of the treatment 
plan resulted in 
decreased 
medication 
adherence in 
some cases.  
Yes, I 
would 
use to 
support 
the use 
of 
educatio
n and its 
potential 
effective
ness even 
in 
individua
ls with 
schizoph
renia. 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Brewer, S., 
Whitten, S., & 
Dziodzio, J. 
(2016). 
Implementation 
of a COPD 
clinical pathway 
with a dedicated 
respiratory 
therapist team. 
TEAM. Respira
tory 
Care, 61(10), 
OF53. 
 
To evaluate the 
effectiveness of a 
clinical pathway to 
reduce readmission 
of COPD patients 
A convenience 
sample of 61 
COPD patients 
admitted to a 
Maine hospital 
A 
multidisciplinary 
task force created 
an inpatient 
COPD pathway 
which included 
standardized 
medication orders. 
Respiratory 
Therapists were 
trained to follow 
the program 
which included 
discharge teaching 
and patient 
materials. 
The Respiratory 
Therapists found that 
the primary medical 
team was unwilling 
to order specialty 
service consults. The 
therapists also found 
that patients felt the 
reason they were 
readmitted is that 
they felt they had 
been discharged too 
early on the previous 
admission. More data 
was required to 
evaluate the 
effectiveness of their 
intervention. 
 
 
 
Level 6: 
Single 
descriptive 
or 
qualitative 
study. 
The study results 
speak more to the 
disadvantages of 
the protocol in 
that they had 
difficulty getting 
providers to 
order. Also, the 
average length of 
stay was slightly 
longer at 4 days 
as opposed to 
3.76 in the control 
group. 
This 
study is a 
lesson 
learned 
in 
evaluatin
g culture 
of the 
organizat
ion 
carefully 
when 
impleme
nting any 
type of 
interventi
on that 
requires 
multidisc
iplinary 
cooperati
on.  
Duncan, P. W., 
Bushnell, C. D., 
Rosamond, W. 
D., Berkeley, S. 
J., Gesell, S. B., 
D'Agostino Jr, 
R. B., & ... 
Sissine, M. E. 
(2017). The 
Comprehensive 
Post-Acute 
To assess the 
effectiveness of a 
comprehensive, 
evidence based, 
post-acute care 
model on patient-
centered outcomes 
40 units in 
North Carolina 
with a 
recruitment 
goal of 6000 
patients (3000 
per arm) 
discharged 
home with a 
stroke or 
transient 
Randomized 
control trial.  
Two days after 
discharge, patients 
in the 
experimental arm 
received a phone 
call and then a 
two-week follow 
up visit. The visit 
included 
The study is ongoing. 
The primary outcome 
is patient reported 
functional status, but 
secondary includes 
medication 
adherence and use of 
community 
resources.  
Level 2: 
Randomize
d Control 
Trial 
The study has not 
completed as of 
yet. It began in 
2015 and is 
ongoing which is 
an indication that 
the study is 
accruing and 
going as well as 
possible. It 
appears from 
Yes, this 
study is 
importan
t 
evidence 
that there 
is merit 
behind 
an 
instrume
nt 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Stroke Services 
(COMPASS) 
study: Design 
and methods for 
a cluster-
randomized 
pragmatic 
trial. BMC 
Neurology, 17, 
(1-13). 
doi:10.1186/s12
883-017-0907-1 
 
ischemic 
attack. 
Patients are 
adults 18 years 
and older with 
stroke or 
transient 
ischemic 
attack who are 
discharged 
home from the 
hospital. 
assessment of 
social and 
functional 
determinants of 
health and an 
individualized 
COMPASS Care 
Plan integrated 
with a 
community-
specific resource 
data based. 
Follow up phone 
calls are made at 
30 and 60 days 
post discharge to 
follow up on 
interventions.  
another search 
that they may 
have lowered 
their total accrual 
goal to 5000 from 
the previous 6000 
goal. (Found 
here: 
https://www.pcori
.org/research-
results/2015/com
paring-ways-
improve-daily-
functioning-
stroke-survivors-
after-they-leave) 
develope
d to help 
identify 
communi
ty 
resources 
and a 
structure
d plan to 
help 
patients 
at high 
risk for 
readmissi
on. 
Flink, M., & 
Ekstedt, M. 
(2016). 
Prerequisites for 
patient self-
management 
learning at 
hospital 
discharge - an 
observational 
multiple case 
study. Internatio
nal Journal of 
Integrated 
Care, 16(6), 1-
The study aim was" 
to explore how the 
hospital discharge 
process provides a 
learning 
environment for 
patients' 
understanding of 
their self-
management." 
Adult patients 
being 
discharged 
from three 
internal 
medicine 
"wards" and 
caregivers/nurs
es in three 
different 
hospitals in 
Sweden.  
This was an 
observational 
case-study design. 
Nurses were 
provided with 
information of 
which much effort 
was put into 
developing, to 
facilitate patient  
understanding  
Information given at 
discharge was driven 
by the needs of the 
staff, as opposed to 
the patient's level of 
understanding. 
Providing 
information alone 
does not promote 
adherence to 
medications. Patients 
must be given the 
time to learn in a 
patient centered way, 
however, due to time 
Level 4: 
case study 
design 
The findings of 
this study were 
not what had been 
hoped by the 
researchers who 
had spent a great 
amount of effort 
developing an 
instrument that 
they hoped would 
be used by nurses 
to improve 
discharge 
teaching and 
The 
importan
t 
takeaway 
here is 
that there 
must be 
care with 
developi
ng 
teaching 
materials 
as a way 
to 
improve 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
2. 
doi:10.5334/ijic.
2768 
 
limitations, patients 
are not involved in 
planning their care.  
medication 
adherence. 
adherenc
e to 
prescribe
d 
regimens
. 
Healthca
re 
workers/
nurses 
have 
little time 
to 
educate 
patients. 
Hanson, R. L., 
Habibi, M., 
Khamo, N., 
Abdou, S., & 
Stubbings, J. 
(2014). 
Integrated 
clinical and 
specialty 
pharmacy 
practice model 
for management 
of patients with 
multiple 
sclerosis. Ameri
can Journal of 
Health-System 
Pharmacy, 71(6
Integrated clinical 
and specialty 
pharmacy practice 
model for 
management of 
patients with 
multiple sclerosis 
This is a 
description of 
a specialty 
pharmacy 
model utilizing 
an 
interdisciplinar
y approach 
including 
physicians, 
nurses, and 
pharmacists.  
High rates of non-
adherence to 
expensive MS 
drugs was 
addressed by 
creating a model 
to incorporate a 
dedicated team to 
address barriers 
including a 
pharmacist, and 
direct interaction 
with the patient.  
The model improves 
patient compliance 
Level 7: 
Expert 
Opinion 
The model may 
not be 
reproducible 
because it 
involves an 
investment of 
time and 
resources. Not all 
clinics have 
pharmacists 
available to help 
with medication 
teaching.  
Yes, this 
model 
describes 
somethin
g similar 
to an 
interdisci
plinary 
team 
model 
that is 
missing 
from 
some 
units in 
the 
hospital. 
These 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
), 463-469. 
doi:10.2146/ajh
p130495 
 
teams 
can help 
address 
barriers 
that 
patients 
may have 
to 
successfu
l 
adherenc
e to 
home 
medicati
ons. 
Lafeuille, M., 
Frois, C., 
Cloutier, M., 
Duh, M. S., 
Lefebvre, P., 
Pesa, J., & ... 
Durkin, M. 
(2016). Factors 
associated with 
adherence to the 
HEDIS quality 
measure in 
Medicaid 
patients with 
schizophrenia. A
merican Health 
& Drug 
To assess the impact 
of  baseline 
schizophrenia 
patient 
characteristics on 
adherence to 
antipsychotic 
medications  
12,990 
Patients with 
schizophrenia 
between the 
ages of 25-64 
on at least one 
antipsychotic 
medication 
Descriptive 
review of 
Medicaid 
healthcare claims 
data between 
2008 and 2011 
from five states - 
to identify 
Patients who showed 
adherence as a 
baseline 
characteristic and on 
one particular 
medication showed 
continued adherence 
Level 6: 
descriptive 
study 
This is a review 
of information 
found in a 
database and is 
completely 
dependent on the 
accuracy of the 
database,  
Yes, this 
helps to 
develop 
the 
assessme
nt 
instrume
nt in that 
if 
patients 
are 
already 
adherent 
they are 
likely to 
continue 
to be 
adherent.  
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Benefits, 9(7), 
399-409 
Patel, S. D., 
Phuoc Anh 
(Anne), N., 
Bachler, M., & 
Atkinson, B. 
(2017). 
Implementation 
of postdischarge 
follow-up 
telephone calls 
at a 
comprehensive 
cancer 
center. America
n Journal of 
Health-System 
Pharmacy, 74, 
S42-S46. 
doi:10.2146/ajh
p160805 
 
To reduce within 30 
day readmissions by 
developing and 
implementing a 
pharmacy-driven 
postdischarge 
follow-up telephone 
call program to 
assess adherence to 
medications, 
educate, and address 
concerns  
Convenience 
sample of 
pharmacists 
employed by 
MD Anderson 
Cancer Center 
and patients 
discharged 
during the 
study period 
Pharmacists were 
trained in a 
transition-of-care 
telephone call 
program. Patients 
were called and 
asked the 
questions to 
determine 
adherence, answer 
questions, and 
address 
discrepancies.  
Patients who 
received the phone 
calls were less likely 
to be rehospitalized 
within 30 days 
following discharge. 
Out of 206 calls 
completed, 87 
patients were found 
to have discrepancies 
in their medication 
regimen.  
Level 4 
Cohort 
Study 
Convenience 
sample using a 
pilot instrument 
for the phone 
interview.  
Yes. 
Although 
it is not a 
strong 
study on 
its own, 
with 
additiona
l similar 
evidence 
this 
could 
support 
the 
usefulnes
s of 
pharmaci
st follow 
up and/or 
use of a 
specific 
instrume
nt when 
calling 
patients 
after 
discharge
. 
Tomko, J. R., 
Ahmed, N., 
Mukherjee, K., 
To evaluate a 
pharmacist-driven 
discharge 
Adult patients 
discharged  
from a 
Retrospective  
review of patient 
charts 
30 day hospital 
readmission rates 
were significantly 
Level 6: 
Single 
descriptive 
This may not be 
replicable in a 
facility that does 
Yes. This 
study 
showed 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Roma, R. S., 
Dilucente, D., & 
Orchowski, K. 
(2013). 
Evaluation of a 
discharge 
medication 
service on an 
acute 
psychiatric 
unit. Hospital 
Pharmacy, 48(4
), 314-320. 
doi:10.1310/hpj
4804-314.test 
 
medication service 
for hospitalized 
psychiatric patients. 
Patients were 
provided with 
immediate access to 
their medications 
upon discharge.  
behavioral 
health unit to 
home  between 
October 2010 
and November 
2011who were 
prescribed 
psychiatric 
prescriptions 
for self-
administration 
decreased  in studied 
subjects compared to 
total readmissions 
the previous year 
not provide 
ambulatory 
prescription 
services.  
that 
immediat
e 
availabili
ty of 
prescripti
ons upon 
discharge 
combine
d with 
develop
ment of 
support 
decreases 
readmissi
ons of 
psychiatr
ic 
patients. 
Aikens, J. E., 
Trivedi, R., 
Aron, D. C., & 
Piette, J. D. 
(2015). 
Integrating 
support persons 
into diabetes 
telemonitoring 
to improve self-
management 
and medication 
adherence. Jour
nal of General 
To investigate the 
potential benefits for 
medication 
adherence of 
integrating a patient 
-selected support 
person into an 
automated diabetes 
telemonitoring and 
self-management 
program, and to 
determine whether 
these benefits vary 
98 initially 
non-adherent 
adult patients 
Quasi-
experimental 
design in which 
patients chose 
their preference 
for telemonitoring 
vs. interactive 
voice response 
calls.  
This was a three 
to six month 
intervention in 
which the patient 
could choose a 
Out of 98 patients, 
42% opted to involve 
a support person. 
Those who opted for 
the additional 
support person 
demonstrated 
significantly greater 
improvement in 
long-term adherence 
than those who 
participated alone. 
Distress was a 
predictor that the 
Level 4: 
Case 
control 
study 
A weakness is 
that patients 
randomized 
themselves.  
Yes, this 
study 
brings 
the idea 
of 
distress 
as 
predictor
s of 
adherenc
e into the 
picture, 
but also 
indicates 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Internal 
Medicine, 30(3), 
319-326. 
doi:10.1007/s11
606-014-3101-9 
 
by the patients 
baseline of distress. 
support person to 
receive updates 
along with 
guidance 
regarding patient 
assistance. 
Distress was 
measured at 
baseline. 
support person would 
eventually become 
less effective over 
time, but not for 
those who 
participated alone. 
that 
having a 
support 
person is 
importan
t to help 
with 
adherenc
e when 
combine
d with 
additiona
l services 
such as 
telemonit
oring. 
Balling, L., 
Erstad, B. L., & 
Weibel, K. 
(2015). Impact 
of a transition-
of-care 
pharmacist 
during hospital 
discharge. Journ
al of The 
American 
Pharmacists 
Association: 
Japha, 55(4), 
443-448. 
doi:10.1331/JA
To assess the impact 
of a transition-of-
care pharmacist 
during hospital 
discharge 
1011 adult 
patients were 
educated and 
452 
interventions 
by a 
pharmacist 
when 
discharges 
were 
coordinated in 
two inpatient 
units in 
Southern 
Arizona  
August 2012 
to July 2013. 
This was a before 
and after 
comparison where 
a pharmacist 
provided 
education and 
medication 
reconciliation as 
well as 
intervening to 
prevent errors.  
Readmission rate 
dropped and several 
interventions 
included starting an 
omitted medication, 
preventing multiple 
discharge problems 
such as duplication 
of therapy, improper 
dose or quantity, 
inappropriate 
prescription, 
preventing a drug 
interaction etc. 
Level 3 
Control 
trial - no 
randomizati
on 
Convenience 
sample. Not all 
patients benefited 
from the service. 
there is no 
account for 
possible changes 
in acuity, or 
census.  
Yes. This 
article 
adds to 
the 
evidence 
that 
patients 
have 
barriers 
to home 
adherenc
e that 
start in 
the 
hospital 
setting 
and that 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
PhA.2015.1408
7 
 
interventi
on can 
help 
improve 
adherenc
e. 
Kangovi, S., 
Grande, D., 
Meehan, P., 
Mitra, N., 
Shannon, R., & 
Long, J. A. 
(2012). 
Perceptions of 
readmitted 
patients on the 
transition from 
hospital to 
home. Journal 
of Hospital 
Medicine, 7(9), 
709-712. 
doi:10.1002/jhm
.1966 
To collect patient 
reported challenges 
that they believe 
contribute to illness 
relapse 
1084 adult 
inpatients of 
U.Penn and 
Penn 
Presbyterian 
hospitals 
between Nov. 
2010 to July 
2011.  
Cross-Sectional 
Survey 
Issues reported 
included, feeling 
unprepared for 
discharge, difficulty 
with ADLS, trouble 
adhering or accessing 
to discharge 
medications, lack of 
social support.  low 
socioeconomic status 
(Medicaid or 
uninsured)  were 
more likely to report 
difficulty 
understanding and 
executing discharge 
instructions, adhering 
to medications, etc. 
Level 6 
single 
descriptive 
study 
Convenience 
sample 
Yes, this 
study 
provides 
additiona
l 
confirma
tion that 
there are 
risk 
factors 
that may 
be 
included 
in an 
assessme
nt 
instrume
nt.  
Vervloet, M., 
Spreeuwenberg, 
P., Bouvy, M. 
L., Heerdink, E. 
R., de Bakker, 
D. H., & van 
Dijk, L. (2013). 
Lazy Sunday 
afternoons: The 
Investigate  impact 
of deviations from 
prescribed regimen 
in type 2 diabetes 
patients can be 
explained by 
characteristics of the 
individual 
medication intake 
104 non-
adherent type-
2 diabetes 
adult patients 
from 37 
community 
pharmacies 
Observational 
study. Patients 
were monitored 
for 6 months to 
see whether intake 
occurred and 
whether or not 
intake occurred 
within the agreed-
Medications in 
evening and 
weekends and 
holidays are less 
likely to be correctly 
timed and also more 
likely to be 
completely missed. 
The worst day was 
Level 6 
single 
descriptive 
Electronic 
monitoring 
devices do not 
guarantee that it 
is the patient 
accessing the 
medication nor 
that the 
Yes, this 
provides 
a good 
basis for 
consideri
ng 
altering 
timing of 
medicati
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negative impact 
of interruptions 
in patients' daily 
routine on 
adherence to 
oral antidiabetic 
medication. A 
multilevel 
analysis of 
electronic 
monitoring 
data. European 
Journal of 
Clinical 
Pharmacology, 
69(8), 1599-
1606. 
moments and the 
patient 
upon time period 
(correct time) 
Sunday at 33% 
compliance. 
medication was 
actually taken.  
on 
schedule 
for non-
adherent 
patients.  
Peeters, B., Van 
Tongelen, I., 
Duran, Z., 
Yüksel, G., 
Mehuys, E., 
Willems, S., & 
... Boussery, K. 
(2015). 
Understanding 
medication 
adherence 
among patients 
of Turkish 
descent with 
type 2 diabetes: 
a qualitative 
To explore 
perspectives of 
Turkish migrants 
with type 2 diabetes 
on adherence to oral 
hypoglycemic 
agents 
21 adult 
Turkish 
descent 
patients 
recruited from 
primary care 
and 
community 
sources.  
In-depth 
interviews. 
Analysis was 
guided by a 
grounded theory 
approach. 
Healthcare providers 
should explore 
patient perspectives 
of medication 
adherence with their 
patients due to 
several different 
beliefs about 
medications, as well 
as problems with 
forgetfulness, 
feelings of 
depression, and lack 
of social support. 
Level 6 
qualitative 
study 
Small sample Yes, 
combine
d with 
other 
evidence 
this 
article 
reminds 
of some 
of the 
many 
other 
aspects 
that can 
factor 
into non-
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study. Ethnicity 
& Health, 20(1), 
87-105. 
doi:10.1080/135
57858.2014.890
174 
 
adherenc
e.  
National 
Community 
Pharmacist's 
Association. 
(2013). 
Medication 
Adherence in 
America: A 
national report 
card. Retrieved 
from 
http://www.ncp
a.co/adherence/
AdherenceRepo
rtCard_Full.pdf 
 
A national survey 
conducted to 
determine self-
reported adherence 
while also assessing 
demographic, 
attitudinal and 
behavioral factors 
related to 
prescription drug 
compliance. 
1020 
American 
adults aged 40 
and older 
(median age of 
60) prescribed 
ongoing 
medication 
(average of 
four prescribed 
medications) 
for a chronic 
condition (the 
group that uses 
prescription 
medication 
most regularly 
and therefore 
at greatest risk 
for 
nonadherence)
.  
Independent 
random-sample 
telephone survey 
conducted by a 
research firm. 
Survey assessed 
nine nonadherant 
behaviors:, in the 
past 12 months, 
patients failed to 
fill or refill a 
prescription, 
missed a dose, 
took a lower or 
higher dose than 
prescribed, 
stopped a 
prescription early, 
took an old 
medication for a 
new problem, 
took someone 
else’s medicine or 
forgot whether 
they’d taken a 
medication.  
48% earned a grade 
of A or B 36 percent 
a grade of C or D. 15 
percent Predictors 
Regression 
modeling, identified 
the six key predictors 
of adherence. Those 
include – in order of 
magnitude:  
Patients’ personal 
connection with a 
pharmacist or 
pharmacy staff; 
How easy it is for 
them to afford their 
medications;  
The level of 
continuity they have 
in their health care; 
How important 
patients feel it is to 
take their medication 
exactly as prescribed;  
Level 6 
descriptive 
study - 
random 
survey 
A telephone 
survey is 
dependent on the 
honesty of the 
respondent. 
Respondents may 
be reluctant to 
admit undesirable 
behaviors.  
There are 
questions about 
connectedness for 
both doctors and 
pharmacists. The 
study emphasizes 
the connectedness 
with a pharmacist 
as a behavior 
related to 
adherence. The 
study was 
conducted for the 
National 
Community 
Pharmacy 
Association so 
Yes, this 
research 
contains 
useful 
informati
on to 
learn 
about 
reasons 
for non-
adherenc
e and 
methods 
that may 
help 
promote 
adherenc
e. 
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How well informed 
they feel about their 
health; and 
The extent to which 
their medication 
causes unpleasant 
side effects. 
may be somewhat 
biased in the 
questionnaire as 
this has not been 
found in other 
studies.  
Cawthon, C., 
Mion, L., 
Willens, D., 
Roumie, C., & 
Kripalani, S. 
(2014). 
Implementing 
routine health 
literacy 
assessment in 
hospital and 
primary care 
patients. The 
Joint 
Commission 
Journal on 
Quality and 
Patient Safety: 
Joint 
Commission 
Resources, 
40(2): 68-76. 
 
Addressing health 
literacy is a national 
health priority. The 
purpose of this study 
was to measure the 
acceptability, 
adoption, 
appropriateness, 
feasibility, fidelity, 
and sustainability of 
a three-item 
measure called the 
Brief Health 
Literacy Screen 
(BHLS)  
Data was 
collected 
between 
November 
2010 and April 
2012 on 
55,611 adults 
primarily 
middle-aged 
and Caucasian. 
Approximately 
5000 inpatient and 
outpatient nursing 
staff were 
informed and 
educated about 
the instrument. 
The instrument 
was embedded 
into the electronic 
health record and 
asked at 
admission to the 
inpatient or 
outpatient setting:   
Questions 
included: " The 
BHLS consists of 
three questions 
asking about 
confidence filling 
out forms, if they 
ask others to help 
them read hospital 
materials, and 
difficulty learning 
The study found that 
it was feasible and 
efficient to include 
the three-question 
assessment as part of 
the nursing 
assessment process. 
There are 
instruments that are 
lengthier to 
administer, but not 
feasible. This study  
Level  three 
controlled 
trial 
This study was to 
test feasibility of 
implementing a 
three question 
assessment. 
Further study is 
needed to 
evaluate 
effectiveness of 
the instrument. 
Further 
development of 
appropriate 
patient resources 
as well as training 
for nurses to 
administer the test 
were identified. 
Yes, the 
Joint 
Commiss
ion is an 
accrediti
ng body 
of our 
hospital 
system 
and the 
statement
s made 
as well 
as the 
reference
s to the 
importan
ce of 
assessing 
patients' 
specific 
learning 
needs 
holds 
additiona
l weight. 
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about medical 
condition due to 
difficulty 
understanding 
written materials. 
 
Mausbach, B. 
T., Schwab, R. 
B., & Irwin, S. 
A. (2015). 
Depression as a 
predictor of 
adherence to 
adjuvant 
endocrine 
therapy (AET) 
in women with 
breast cancer: a 
systematic 
review and 
meta-analysis. 
Breast Cancer 
Research and 
Treatment, 
152(2), 239-
246. 
doi:10.1007/s10
549-015-3471-7 
To analyze the 
available evidence 
concerning the 
effects of depression 
on non-adherence to 
adjuvant endocrine 
therapy. 
Breast cancer 
patients taking 
endocrine 
therapy with a 
total 
population of 
17,735 patients 
with breast 
cancer. The 
articles were 
published 
between 2004 
to 2014. . 
Systematic review 
and meta-analysis 
Level of 
Evidence: Level 1 
systematic 
Review and meta-
analysis  
Limitations: 1. 
Only 9 studies 
included, 2. all 
studies included 
participants with 
depression but 
only one study 
included this as a 
variable, 3. None 
of the studies 
focused 
exclusively on the 
effect of 
depression on 
adherence. 
The review states 
that as much as 20% 
of breast cancer 
patients are 
depressed. Depressed 
patients tend to be 
less adherent to their 
therapy. Mortality 
may be increased due 
to nonadherence to 
oral therapy. Women 
who are depressed 
had greater financial 
burden, lower quality 
of life, and shorter 
time to recurrence of 
their cancer.  
Level 1 
systematic 
Review and 
meta-
analysis  
 
Limitations 
mentioned in the 
study included. 
all studies 
included 
participants with 
depression but 
only one study 
included this as a 
variable and none 
of the studies 
focused 
exclusively on the 
effect of 
depression on 
adherence. 
Yes, 
study 
supports 
importan
ce of 
treating 
depressio
n to 
improve 
adherenc
e 
Verbrugghe, M., 
Verhaeghe, S., 
Lauwaert, K., 
Beeckman, D., 
& Van Hecke, 
To gain insight into 
the determinants and 
associated factors of 
nonadherence in 
25 studies 
focusing on 
adherence to 
oral anti-
Systematic review 
of literature 
The study found that 
older age, and 
younger age (not 
middle age) along 
with therapy related 
Systematic 
review of 
literature. 
Level one 
evidence 
Patient 
characteristics 
differed widely so 
difficult to 
generalize. 
Yes 
Supports 
importan
ce of 
controlli
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A. (2013). 
Determinants 
and associated 
factors 
influencing 
medication 
adherence and 
persistence to 
oral anticancer 
drugs: A 
systematic 
review. Cancer 
Treatment 
Reviews, 39(6), 
610-621. 
doi:10.1016/j.ctr
v.2012.12.014 
 
 
 
 
 
 
 
 
 
 
 
 
patients taking 
cancer therapy 
cancer therapy 
drugs 
side effects were the 
predominant factors 
in non-adherence. 
Better attention to 
management of side 
effects may help 
patients adhere to 
their oral 
chemotherapy and 
continue to take it 
longer.   
 
  
Approaches may 
need to be 
taylored to each 
person to be 
effective (given a 
choice) 
Only two studies 
used MEMS to 
detect when 
medication vials 
were accessed. 
Patients need to 
be "well-
informed"   
ng side 
effects to 
promote 
adherenc
e 
Bender, C. M., 
Gentry, A. L., 
Brufsky, A. M., 
Casillo, F. E., 
To assess patient 
illness or treatment 
factors that may 
predict 
91 women 
with early 
stage breast 
cancer 
Repeated measure 
design to assess 
adherence 
continuously for 
Found lower 
adherence for women 
with depression, 
anxiety, or symptoms 
Level  6 
repeated 
measure 
design 
Sample size may 
have been a factor 
related to 
cognitive 
 
ADDRESSING BARRIERS TO ADHERENCE  100 
Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
Cohen, S. M., 
Dailey, M. M., . 
. . Sereika, S. 
M. (2014). 
Influence of 
patient and 
treatment 
factors on 
adherence to 
adjuvant 
endocrine 
therapy in breast 
cancer. 
Oncology 
Nursing Forum, 
41(3), 274. 
doi:10.1188/14.
ONF.274-285 
nonadherence to 
endocrine therapy 
receiving 
endocrine 
therapy 
the first 18 
months of 
endocrine therapy. 
Assessments 
completed at four 
time points to 
measure 
adherence rates 
between 
beginning and 18 
months. 
of illness prior to 
starting therapy. 
Adherence to 
endocrine therapy 
was lower in first 
eight months for 
those with negative 
mood. Women with 
breasts cancer may 
be at risk for 
nonadherence if they 
experience 
depression or anxiety 
and symptoms prior 
to initiating therapy. 
function. More 
research is needed 
to clarify 
cognitive function 
in adherence. 
Greer, J. A., 
Amoyal, N., 
Nisotel, L., 
Fishbein, J. N., 
Macdonald, J., 
Stagl, J., . . . 
Pirl, W. F. 
(2016). A 
systematic 
review of 
adherence to 
oral 
antineoplastic 
therapies. 
Oncologist, 
To determine causes 
of nonadherence and 
factors that may 
help promote 
adherence.  
63 studies of 
adults with 
cancer who are 
prescribed oral 
chemotherapy 
drugs. Studies 
published 
between 
Jaunary 1, 
2003 to June 
30, 2015. 
Systematic 
literature review 
Adherence to 
endocrine therapy 
decreased over time 
to about 50% 
adherence by the 5th 
year.  
Depression played a 
significant role in 
adherence, especially 
in younger adults. 
Asking patients 
about adherence in 
the affirmative such 
as "What percentage 
of the time did you 
Level 1: 
Systematic 
Review 
 
  
The researchers 
found very 
significant 
limitations in 
most of the 
studies they 
reviewed, mostly 
concerning bias. 
In fact all but 
three studies were 
felt to be very 
biased. Authors 
felt more study is 
needed to 
determine 
Yes, I 
will use 
this for 
the 
informati
on 
regarding 
the effect 
of 
depressio
n on 
adherenc
e partly 
because 
the same 
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21(3), 354-376. 
doi:10.1634/the
oncologist.2015
-0405 
take your 
medications" or 
"How well did you 
take your 
medications last 
month" as opposed to 
"How many pills did 
you miss" may yield 
more reliable and 
accurate responses. 
Overall, adherence 
declines over time 
with varying reasons. 
effective 
promotion of 
adherence. 
 
is 
substanti
ated by 
other 
studies as 
well, 
however, 
the 
questions 
asked in 
the 
individua
l studies 
to help 
determin
e 
individua
l 
adherenc
e factors 
and 
adherenc
e were 
felt to be 
biased by 
the 
researche
rs doing 
the 
literature 
review.  
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Kaiser Family 
Foundation. 
(2017). Public 
opinion on 
prescription 
drugs and their 
prices. [online 
slide 
presentation of a 
2015-2017 
tracking poll]. 
Retrieved from 
https://www.kff.
org/slideshow/p
ublic-opinion-
on-prescription-
drugs-and-their-
prices/ 
 
A public opinion 
poll on prescription 
drugs and their 
prices 
1171 adults 
age 18 and 
older  
Telephone survey 
-  Adults were 
surveyed by 
telephone between 
April 17-23, 2017 
weighted to 
balance the 
sample 
demographics to 
match estimates 
of the national 
population 
according to the 
2015 census 
bureau (KFF.org, 
2017) 
One in five adults 
reported taking at 
least four 
prescription drugs 
with 55% taking at 
least one.  
35% of patients 
taking four or more 
prescription pills 
reported taking lower 
dosage, or skipped 
doses (and if 
uninsured did not fill 
the prescription) 
compared to 25% of 
those taking three or 
fewer. Income of 
$40,000 a year or 
less was another 
predictive factor of 
lowering, skipping, 
or not filling a 
prescription. 
Level  6 
survey 
Convenience 
sample that may 
include sampling 
error and bias 
based on adults 
willing to answer 
questions over the 
phone could 
misrepresent the 
population as a 
whole.  
Yes, this 
is a 
useful 
survey to 
help 
determin
e 
warning 
signs and 
barriers 
Parr, K. (2017). 
Health literacy: 
Improving 
understanding 
of discharge 
instructions. 
Unpublished 
manuscript, 
School of 
Nursing, Liberty 
To improve patient 
satisfaction and 
understanding of 
discharge 
instructions by 
factoring in literacy 
into discharge 
instructions and 
using teach-back to 
Adults aged 18 
- 89 having 
outpatient 
surgery 
without 
cognitive 
impairments.  
 
Instructions were 
provided to 
patient at a 5th to 
6th grade reading 
level with pictures 
if needed. Patients 
were asked to 
teach-back what 
they learned. Data 
was collected one 
OAS CAHPS survey 
showed positive 
results; however, the 
sample of surveys 
returned was 
insufficient to show 
statistical 
significance. The 
Likert survey did 
show that patients 
Level 6 
single 
descriptive 
pilot study 
Returned surveys 
did not show a 
statistical 
difference in 
CAHPs survey 
partly due to 
limited time 
frame of study 
and limited 
Yes, this 
speaks 
well to 
how 
literacy 
impacts 
patient 
educatio
n, as well 
as 
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University, 
Lynchburg, Va.  
 
assess 
understanding. 
month for patients 
discharged and 
compared to 
previous 
satisfaction 
scores. A Likert 
scaled phone 
survey was also 
used to collect 
information.  
felt better prepared 
and better educated 
for discharge home 
after surgery.  
sample of 
returned surveys. 
supportin
g the 
teach-
back 
method 
of patient 
educatio
n  
Boucher, J., 
Lucca, J., 
Hooper, C., 
Pedulla, L., & 
Berry, D. L. 
(2015). A 
structured 
nursing 
intervention to 
address oral 
chemotherapy 
adherence in 
patients with 
non-small cell 
lung cancer. 
Oncology 
Nursing Forum, 
42(4), 383. 
 
To evaluate a nurse-
led intervention to 
enhance mediation 
knowledge and 
adherence using the 
Multinational 
Association for 
Supportive Care in 
Cancer Oral Agent 
Teaching Instrument 
(MOATT) 
30 adult 
patients with 
lung cancer 
Longitudinal 
descriptive 
feasibility study to 
assess a structured 
nurse-led 
education session 
using MOATT. A 
72 hour phone 
follow up was 
provided after 
initiatial education 
of the participant. 
Participants 
completed a 
knowledge rating 
scale, adherence 
scale at the end of 
the first cycle of 
oral 
chemotherapy. 
The structured 
MOATT program 
were feasible for the 
program, and the 
adherence and 
knowledge outcomes 
were encouraging. 
Additional studies 
are needed to 
measure objective 
adherence measures 
and strategies for 
delivering supportive 
care to patients in 
their homes. 
Level 6 
longitudinal 
descriptive 
feasibility 
study 
The findings were 
applicable to a 
single drug, 
erlotinib. Due to 
the single arm 
study the article 
states that proof 
of improvement is 
not possible for 
this study despite 
encouraging 
results. 
It adds to 
the 
knowled
ge 
however 
it is a 
small 
study. 
Spoelstra, S. L., 
& Sansoucie, H. 
(2015). Putting 
To develop a 
synthesis of the 
literature 
Extensive 
review of 
literature on 
Comprehensive 
review of 
literature 
The literature 
supports using 
patient feedback and 
Level 1 
systematic 
review of 
Information about 
technology 
becomes outdated 
Yes, this 
is a 
helpful 
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evidence into 
practice: 
Evidence-based 
interventions for 
oral agents for 
cancer. Clinical 
Journal of 
Oncology 
Nursing, 19(3), 
60-72. 
doi:10.1188/15.
S1.CJON.60-72 
 
 
 
surrounding the 
issue of adherence 
and identify 
effective 
interventions for the 
promotion, 
treatment, and 
management of 
adherence to oral 
agents for cancer.  
the topic of 
medication 
adherence. 
Adult Patients 
with cancer as 
well as other 
populations 
were included. 
The review 
was conducted 
in 2014 and 
included data 
within a ten-
year time-
frame. 
including a 
"weight of 
evidence 
classification 
schema to assess 
levels of evidence 
of each source. 
Limitation: 
technology has 
changed since 
review  
 
 
multicomponent 
interventions. 
Literature also 
suggests that text 
messaging, 
automated voice 
response and 
treatment of 
depression are likely 
to be effective 
methods of 
promoting adherence 
to oral medications.  
Factors effecting 
adherence included 
decreased dosing to 
once a dya to 
improve adherence.  
research 
combined 
with level 5 
review of 
literature  
quickly and there 
is a warning that 
this could be the 
case for any 
technology 
recommended in 
this article. 
review 
with 
combine
d 
evidence 
to 
support 
various 
strategies 
to help 
with 
adherenc
e. 
Irwin, M., & 
Johnson, L. A. 
(2015). Factors 
influencing oral 
adherence: 
Qualitative 
metasummary 
and 
triangulation 
with 
quantitative 
evidence. Clinic
al Journal of 
Oncology 
Nursing, 19(3), 
A review to 
synthesize evidence 
regarding factors 
that impact 
medication 
adherence and to 
identify implications 
for practice. 
159 research 
studies from 
PubMed and 
CINAHL:  
83 
Quantitative; 
46 qualitative; 
17 mixed-
methods; 9 
systematic 
reviews; 3 
meta-analysis; 
and 1 
integrated 
review. Study 
Qualitative 
metasummary and 
triangulation with 
quantitative 
evidence. 
Evidence includes 
Systematic 
Reviews and 
Meta-analysis, 
quantitative 
studies, and 
mixed methods 
studies.  
Forty-four factors 
were identified to 
have an influence on 
adherence.  
Level 1 
meta-
analysis 
with 
triangulatio
n 
 
Qualitative 
studies may 
contain varied 
classification of 
themes and 
concepts. This 
was adjusted by 
secondary review 
to establish 
reliability. 
Yes, this 
is very 
helpful 
for 
establishi
ng a very 
reliable 
list of 
warning 
signs to 
barriers 
with 
multiple 
research 
studies 
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6-30. 
http://dx.doi.org
.ezproxy.liberty.
edu/10.1188/15.
S1.CJON.6-30 
 
samples 
ranged from 
10 to 101,028. 
Large studies 
utilized 
insurance and 
pharmacy 
databases for 
descriptive 
analysis. 
supportin
g the 
prevalen
ce and 
impact of 
each 
barrier.  
Wooldridge, K., 
Schnipper, J. L., 
Goggins, K., 
Dittus, R. S., 
&Kripalani, S. 
(2016). 
Refractory 
primary 
medication 
nonadherence: 
Prevalence and 
predictors after 
pharmacist 
counseling at 
hospital 
discharge. J. 
Hosp. Med., 11, 
48–51. 
doi:10.1002/jhm
.2446 
To evaluate the 
prevalence and 
predictors of 
refractory primary 
nonadherence in 
patients hospitalized 
with acute 
cardiovascular 
conditions who 
received counseling 
from a pharmacist 
before discharge. 
341 patients 
who received 
discharge 
counseling 
during a 
previous 
pharmacist 
study and had 
new 
medications to 
be filled. Mean 
age was 61.3 
years. 
Data was obtained 
from medical 
record review and 
follow up phone 
calls.  
The primary outcome 
was percentage of 
patients who reported 
not filling at least 
one discharge 
prescription. Patients 
were asked to 
provide a reason the 
medication was not 
filled.  
Single marital status, 
lower income, and 
having more than 10 
medications were 
significantly 
associated with not 
filling medications. 
Reasons included 
cost by 23.5% of 
patients. Additional 
reasons include lack 
of time to go to the 
pharmacy, 
Level 6 
single 
descriptive 
study 
No limitations 
were mentioned 
however, the 
study may be 
difficult to 
replicate for many 
institutions do not 
have pharmacy 
staff to support.  
Yes, it 
adds to 
the 
knowled
ge of 
warning 
signs and 
barriers 
to 
adherenc
e. 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
medication not 
delivered or 
dispensed, and 
inability to afford the 
medications.  
Barthélémy, P., 
Asmane-De la 
Porte, I., Meyer, 
N., Duclos, B., 
Serra, S., 
Dourthe, L.-M., 
. Kurtz, J.-E. 
(2014). 
Adherence and 
patients' 
attitudes to oral 
anticancer 
drugs: A 
prospective 
series of 201 
patients 
focusing on 
targeted 
therapies. 
Oncology, 
88(1), 1. 
doi:10.1159/000
366226 
 
To see if patients 
who receive an 
education regarding 
importance of 
adherence to five 
full years of 
hormonal therapy 
felt better informed 
and adhered to their 
therapy longer 
201 women 
with various 
stages of 
breast cancer 
in Alsace, 
France 
between 2012 
and 2013. 
A 15-item survey 
was given to 
patients located 
on four oncology 
units.  
The researchers 
concluded that better 
education, and 
education repeated at 
intervals throughout 
therapy could be 
beneficial to 
increasing adherence 
to oral therapies of 
all types.  
Level 6 
single 
descriptive 
study 
The researchers 
did not ask if the 
patients had 
educated 
themselves in any 
way. 
Yes, this 
supports 
the vast 
literature 
on the 
importan
ce of 
educatio
n in the 
presence 
of some 
literature 
that 
implies a 
limit on 
its 
effective
ness. It 
may be 
more 
about the 
method 
and 
timing, 
than 
simply 
checking 
it off a 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
list as a 
one-time 
task. 
Moss, R. C., 
Lowe, G. C., 
Frampton, C. 
A., & Revell, P. 
(2014). A nurse-
led randomised 
controlled trial 
of a structured 
educational 
programme for 
patients starting 
warfarin 
therapy. Journal 
of Research in 
Nursing, 19(5), 
402-412. 
doi:10.1177/174
4987113515261 
 
To see if a 
structured 
educational program 
at implementation of 
an oral medication 
improves 
knowledge, 
satisfaction and 
therapeutic benefits 
of the drug 
A randomized 
controlled trial 
of 45 
hospitalized 
patients being 
discharged on 
warfarin 
 
divided into two 
groups, one 
receiving the 
“usual” care, and 
the other provided 
with structured 
counseling and an 
educational video. 
Both groups were 
administered 
questionnaires at 
discharge and 
again at 3 months. 
Both groups were 
also assessed for 
satisfaction and 
time in 
therapeutic INR. 
Patients who 
received the 
intervention had 
significantly better 
knowledge of their 
therapy than the 
control group. In 
addition, they also 
reported improved 
satisfaction and 
better time in the 
target INR range. 
 
 
 
 
Level 2 
randomized 
controlled 
trial 
A relatively small 
number of 
patients in one 
location  limits 
generalization 
Yes, it 
adds to 
the 
multitude 
of 
literature 
confirmi
ng that 
educatio
n 
provided 
in initial 
and 
concurre
nt time 
periods is 
beneficia
l 
Murphy, C. C., 
Bartholomew, 
L. K., 
Carpentier, M. 
Y., Bluethmann, 
S. M., & 
Vernon, S. W. 
(2012). 
Adherence to 
adjuvant 
hormonal 
To assess for 
barriers to 
adherence 
This is a 
review of 
twenty-nine 
peer-reviewed, 
primary 
studies of 
female breast 
cancer 
survivors 
taking 
endocrine 
Nonadherence 
rates were as high 
as 71% at five 
years. Factors that 
were attributed to 
improved 
adherence 
included taking 
more medications 
at baseline, 
referral to an 
The study concludes 
that many of these 
factors are not 
modifiable and that 
further research is 
needed to identify 
potentially 
modifiable factors so 
that interventions can 
be developed to 
improve adherence 
Level 1 
systematic 
review of 
primary 
research 
studies 
Data was 
collected up to 
2012 which limits 
to certain types of 
therapies taken. 
New therapies 
have been 
developed which 
may have 
impacted the rates 
of nonadherence 
Yes, this 
is a good 
study 
helping 
to 
identify 
some of 
the most 
common 
barriers 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
therapy among 
breast cancer 
survivors in 
clinical practice: 
a systematic 
review. Breast 
Cancer 
Research and 
Treatment, 
134(2), 459-
478. 
doi:10.1007/s10
549-012-2114-5 
 
therapy 
published 
between 1998 
and 2012. 
 
 
oncologist and 
earlier year of 
diagnoses. The 
factors attributed 
to worse 
adherence 
included older 
age, increased 
out-of-pocket 
costs, switching 
therapies and side 
effects. 
and decrease 
mortality related to 
non-adherence. 
in women on 
endocrine 
therapy. 
Roop, J. C., & 
Wu, H.-S. 
(2014). Current 
practice patterns 
for oral 
chemotherapy: 
results of a 
national survey. 
Oncology 
Nursing Forum, 
41(2), 185-
A110. 
doi:10.1188/14.
ONF.41-02AP 
 
The three-phase 
study purpose was 
to develop, validate 
and implement a 
national online 
survey regarding 
current practice 
patterns in nursing 
when caring for 
patients prescribed 
oral chemotherapy 
treatments. The 
survey was 
developed to 
explore and describe 
current nursing 
practices especially 
regarding challenges 
related to caring for 
The survey 
was sent to 
5000 nurses 
who were 
members of 
the oncology 
nursing 
society. 577 
nurses 
responded. 
51% of the 
nurses worked 
in practices 
that had 
developed 
specific 
policies and 
procedures and 
resources for 
This is a survey 
study. The survey 
contained 17 
force-choiced 
items and one 
free-text item. 
The most frequently 
identified barriers to 
adherence were cost 
and adverse effects 
of the medication. 
The free-text column 
responses have an 
interesting common 
theme regarding 
erratic procedures 
and inadequate 
interdisciplinary 
communication. 
Level 6 
survey 
study 
This study has the 
limitations of an 
online survey in 
which a 
convenience 
sample is 
included which 
may represent a 
select group of 
nurses who have 
time and are 
willing to 
complete a 
survey. 
Yes, this 
survey 
free text 
informati
on 
confirms 
inadequa
te 
interdisci
plinary 
communi
cation is 
identified 
as a 
factor 
that may 
contribut
e to 
lower 
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Article Title, 
Author Study Purpose Sample  Methods Study Results 
Level of 
Evidence  
Study 
Limitations 
Would 
Use as 
Evidenc
e to 
Support 
a 
Change?  
patients taking oral 
chemotherapy, and 
to identify common 
barriers to treatment 
adherence in 
patients. 
patients taking 
oral therapy. 
 
 
 
 
 
adherenc
e of 
medicati
on in 
patients. 
It also 
supports 
cost and 
adverse 
effects as 
two 
common 
barriers 
to 
adherenc
e.  
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APPENDIX B: Permission to use The Iowa Model Revised and Implementation Strategies 
for Evidence-Based Practice 
 
Permission to Use the Iowa Model Revised: Evidence-Based Practice to Promote 
Excellence in Health Care 
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com> 
Sun 12/10/2017 9:40 PM 
 
To: Washburn, Donna (Nursing) <djwashburn@liberty.edu>; 
 
You have permission, as requested today, to review and/or reproduce The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health 
Care. Click the link below to open. 
 
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care 
 
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the 
internet. 
Citation: Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: Revisions and validation. Worldviews on Evidence-Based Nursing, 14(3), 175-182. 
doi:10.1111/wvn.12223 
In written material, please add the following statement: 
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. For permission to use or reproduce, please contact the University of Iowa 
Hospitals and Clinics at 319-384-9098. 
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions. 
 
 
Permission to use Implementation Strategies for EBP 
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com> 
 Reply| 
Sun 12/10/2017, 9:40 PM 
Washburn, Donna (Nursing) 
You have permission, as requested today, to review and/or use the Implementation Strategies for EBP (Evidence-Based Practice Implementation 
Guide ©). Click the link below to open. 
 
Implementation Strategies for Evidence-Based Practice  
 
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the internet. 
 
Citation: Cullen, L., & Adams, S. L. (2012). Planning for implementation of evidence-based practice. Journal of Nursing Administration, 42(4), 
222-230. doi:10.1097/NNA.0b013e31824ccd0a 
In written material, please include the following statement: 
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2012. For permission to use or reproduce, 
please contact the University of Iowa Hospitals and Clinics at 319-384-9098. 
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions. 
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APPENDIX C: CITI Training Completion Certificate 
 
COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM) 
COMPLETION REPORT COURSEWORK TRANSCRIPT 
COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM) 
COMPLETION REPORT - PART 1 OF 2 COURSEWORK REQUIREMENTS* 
 
NOTE: Scores on this Requirements Report reflect quiz completions at the time all requirements 
for the course were met. See list below for details. See separate Transcript Report for more recent 
quiz scores, including those on optional (supplemental) course elements. 
 
Name: Donna Washburn (ID: 1645501) 
Email: Djwashburn@liberty.edu 
Institution Affiliation: Liberty University (ID: 2446) 
Institution Unit: Nursing 
 
Curriculum Group: Biomedical Research - Basic/Refresher 
Course Learner Group: Biomedical & Health Science Researchers 
Stage: Stage 1 - Basic Course 
Description: Choose this group to satisfy CITI training requirements for Investigators and staff 
involved primarily in biomedical research with human subjects. 
 
Report ID: 20817799 
Completion Date: 10-Sep-2016 
Expiration Date: 10-Sep-2019 
Minimum Passing: 80 
Reported Score*: 98 
 
 
REQUIRED AND ELECTIVE MODULES ONLY DATE 
COMPLETED 
SCORE 
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Belmont Report and CITI Course Introduction (ID: 1127) 04-Mar-2010 3/3 
  (100%) 
History and Ethics of Human Subjects Research (ID: 498) 17-Mar-2010 7/7 
  (100%) 
Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 2) 17-Mar-2010 4/5 (80%) 
Informed Consent (ID: 3) 17-Mar-2010 4/4 
  (100%) 
Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 4) 18-Mar-2010 4/4 
  (100%) 
Records-Based Research (ID: 5) 18-Mar-2010 2/2 
  (100%) 
Genetic Research in Human Populations (ID: 6) 18-Mar-2010 2/2 
  (100%) 
Populations in Research Requiring Additional Considerations and/or Protections (ID: 16680) 10-Sep-2016 5/5 
  (100%) 
FDA-Regulated Research (ID: 12) 18-Mar-2010 5/5 
  (100%) 
Research and HIPAA Privacy Protections (ID: 14) 28-Sep-2015 5/5 
  (100%) 
Vulnerable Subjects - Research Involving Workers/Employees (ID: 483) 28-Sep-2015 4/4 
  (100%) 
Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical 
Research 
10-Sep-2016 5/5 
(ID: 14777)  (100%) 
Conflicts of Interest in Research Involving Human Subjects (ID: 488) 18-Mar-2010 2/2 
  (100%) 
Liberty University (ID: 15111) 10-Sep-2016 No Quiz 
 
For this Report to be valid, the learner identified above must have had a valid affiliation with the CITI Program subscribing institution 
identified above or have been a paid Independent Learner. 
 
Verify at: https://www.citiprogram.org/verify/?694a5a80-3014-4f34-8e0a-31434f88ec20 
 
CITI Program 
Email: support@citiprogram.org Phone: 888-529-5929 
Web: https://www.citiprogram.org 
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COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM) 
COMPLETION REPORT - PART 2 OF 2 COURSEWORK TRANSCRIPT** 
 
** NOTE: Scores on this Transcript Report reflect the most current quiz completions, including 
quizzes on optional (supplemental) elements of the course. See list below for details. See 
separate Requirements Report for the reported scores at the time all requirements for the course 
were met. 
 
Name: Donna Washburn (ID: 1645501) 
Email: Djwashburn@liberty.edu 
Institution Affiliation: Liberty University (ID: 2446) 
Institution Unit: Nursing 
 
Curriculum Group: Biomedical Research - Basic/Refresher 
Course Learner Group: Biomedical & Health Science Researchers 
Stage: Stage 1 - Basic Course 
Description: Choose this group to satisfy CITI training requirements for Investigators and staff involved primarily in biomedical research 
with human subjects. 
 
Report ID: 20817799 
Report Date: 13-Sep-2016 
Current Score**: 100  
 
 
REQUIRED, ELECTIVE, AND SUPPLEMENTAL MODULES MOST 
RECENT 
SCORE 
History and Ethics of Human Subjects Research (ID: 498) 13-Sep-2016 7/7 (100%) 
Students in Research (ID: 1321) 13-Sep-2016 5/5 (100%) 
Liberty University (ID: 15111) 10-Sep-2016 No Quiz 
Informed Consent (ID: 3) 13-Sep-2016 5/5 (100%) 
Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 4) 13-Sep-2016 4/4 (100%) 
Belmont Report and CITI Course Introduction (ID: 1127) 13-Sep-2016 3/3 (100%) 
Records-Based Research (ID: 5) 13-Sep-2016 3/3 (100%) 
Genetic Research in Human Populations (ID: 6) 13-Sep-2016 5/5 (100%) 
Vulnerable Subjects - Research Involving Prisoners (ID: 8) 13-Sep-2016 4/4 (100%) 
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Vulnerable Subjects - Research Involving Children (ID: 9) 13-Sep-2016 3/3 (100%) 
Vulnerable Subjects - Research Involving Pregnant Women, Human Fetuses, and Neonates (ID: 10) 13-Sep-2016 3/3 (100%) 
FDA-Regulated Research (ID: 12) 13-Sep-2016 5/5 (100%) 
Research and HIPAA Privacy Protections (ID: 14) 28-Sep-2015 5/5 (100%) 
Vulnerable Subjects - Research Involving Workers/Employees (ID: 483) 28-Sep-2015 4/4 (100%) 
Hot Topics (ID: 487) 13-Sep-2016 No Quiz 
Conflicts of Interest in Research Involving Human Subjects (ID: 488) 13-Sep-2016 5/5 (100%) 
Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 2) 13-Sep-2016 5/5 (100%) 
Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical Research 
(ID: 14777) 
10-Sep-2016 5/5 (100%) 
Populations in Research Requiring Additional Considerations and/or Protections (ID: 16680) 10-Sep-2016 5/5 (100%) 
 
 
For this Report to be valid, the learner identified above must have had a valid affiliation with the CITI Program subscribing institution 
identified above or have been a paid Independent Learner. 
 
Verify at: https://www.citiprogram.org/verify/?694a5a80-3014-4f34-8e0a-31434f88ec20 
 
Collaborative Institutional Training Initiative (CITI Program) 
Email: support@citiprogram.org Phone: 888-529-5929 
Web: https://www.citiprogram.org 
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APPENDIX D: Medication Adherence Barrier Identification Instrument 
(Version used for data collection) 
 
Medication Adherence Barrier Identification Instrument  
Instructions for use in practice: Place a check next to each warning sign, then mark associated 
potential barrier identified (Refer to an oncology navigator for further evaluation and 
coordination of interdisciplinary care) 
For Data Collection: Gender:_____Year of Birth:______ Unique ID:______________ OSS 
Following: y/n 
Barrier: Warning Signs: Notes: 
(referrals/interven
tions) 
  Financial/Social 
Support 
o Age 65 or higher and one or more of the 
following: 
o Unmarried and/or absence of social support  
o Medicaid eligible 
o Income less than 50,000 dollars/year 
o Limited pharmacy access (location of residence 
related to pharmacy, resides outside of city, lack 
of transportation) 
 
  Depression/Distress/ 
Anxiety 
o PHQ-9 Depression screen Score of = / > 15 
o NCCN Distress Score of = / > 4  
o Diagnoses of anxiety, or on medication for 
anxiety 
(PHQ-9, NCCN 
scores represent 
“Current 
screening”) 
  Medical Related 
Concerns 
 
Related cues:  Side 
effects/Effectiveness/Medicatio
n Reconciliation 
Issues/relationship with 
provider/multiple 
comorbidities/ Polypharmacy/ 
Poor Performance Score 
(ECOG)/cancer therapy last 6 
months 
o More than 10 medications 
o Uncontrolled illness  
o Unexpected side effects and/or lack of expected 
side effects  
o Distressed about side effects 
o Prescription not filled or refilled at expected rate  
o Late stage of cancer 
o Poor physical status (ECOG 1 or over) 
o Provider relationship strained  
o No show for appointments and reluctance to 
reschedule/Requesting a different provider  
o Significant other concerns about not following 
treatment regimen 
Greater than 10 
prescribed 
medications?  
 
Record # of meds 
here and consider 
consult:______ 
  Behavior/Lifestyle  
 
 Related cues: 
Forgetting/Don't think it's 
needed/Didn't "agree" to take 
it/Don't like taking it/ too 
busy/Away from home/no 
established routine 
o Prescription not refilled at expected intervals 
o Pill bottle contains more pills than it should 
based on fill date (If it is the original bottle) 
o Taking additional unprescribed herbal or 
"natural" substances 
o Tobacco, ETOH abuse, illegal drug use 
o Weekly/daily pill box contains unopened/unused 
pills 
o Reluctance to accept a change in regimen 
o Preference to be "prescription free" or "all 
natural" or other alternatives 
 
  Educational o English is not first language  
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Related cues: Knowledge 
deficits including general 
knowledge/limited English 
proficiency/functional/Cogniti
ve/Psychological/Health 
literacy/Untreated Vision or 
Hearing Impairment/Memory 
impairment/misconceptions 
/Distrust 
o Reluctance, difficulty, or inability to read and/or 
correctly explain written medication instructions 
(on pill bottle or med list) 
o Medication not taken correctly 
o Identifies medications by color, size, and shape 
but unable to explain what medications are, or 
what they are for.  
o Has not filled prescription/reluctant to answer 
questions about compliance with regimen 
o Significant other takes care of all paperwork 
o Known memory impairment 
Uncontrolled Chronic 
Illness: 
Signs/Symptoms: Related Medication:  
  Diabetes  
 
 
 
  Hypertension/C
VD 
 
 
 
 
  Renal 
Impairment 
 
 
 
 
  Sustained 
uncontrolled 
depression/Ment
al Illness  
 
 
 
  COPD  
 
 
 
Unplanned Care:                                     Sign/Symptom/Diagnoses Related or possibly related 
med 
  Clinic Visit   
  Emergency 
Room Visit 
  
  Hospitalization   
Talking points: 
 Over 300 billion dollars spent on prescription drugs in 2015 (DC, 2017) 
 Mental health and non-communicable disease are expected to exceed 65% of the global burden of disease 
in 2020; however 50% to 60% of patients (especially those with chronic diseases) are nonadherant to the 
medicine prescribed (Lam & Fresco, 2015). 
 50% to 70% of prescriptions make it to the pharmacy, 48% to 66% come out of a pharmacy, 25% to 30% 
are taken properly, and only 15% to 20% are refilled as prescribed (Millionhearts.hhs.gov, 2017). 
 Successful therapy with medication is key to combating challenges with public health in both developed 
and developing countries. Therefore health care professionals and researchers need to do everything 
possible to improve adherence to medication regimens (Lam & Fresco, 2015). 
 Definition of adherence: The World Health Organization definition of adherence: "the extent to which the 
persons' behavior (including medication-taking) corresponds with agreed upon recommendations from a 
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healthcare provider" and includes the initiation, continuation and discontinuation of the therapy as directed 
(Lam & Fresco, 2015; WHO, 2003). 
 The CMS (Centers for Medicare and Medicaid Services) posted new measure information forms such as 
the NQF 2468: Adherence to Oral Diabetes Agents for Individuals with Diabetes Mellitus. CMS will look 
at databases of individuals prescribed at least two oral diabetes agents in 12 months. Specifically they will 
look at adherence to the oral diabetes medications by checking if prescriptions are filled. In addition, this 
measure is paired with two additional measures to check adherence to statins and ACEIs and ARBs for 
individuals with diabetes (CMS, 2017). 
 A qualitative metasummary and triangulation with quantitative evidence provided forty-four factors 
influencing adherence from 159 studies of patients with and without cancer. Factors included provider 
relations, side effects, forgetfulness, and beliefs about medication necessity, establishing routines for taking 
medication, social support, and ability to fit medications into lifestyle, cost, and medication knowledge. 
Depression and negative expectations of results also had a negative effect on adherence (Irwin, & Johnson, 
2015). This study was the most helpful in identifying the most prevalent barriers to adherence with multiple 
studies confirming each one.   
 
Barrier References and Notes: 
1.Finances/ 
Social support 
Cost can be a deterrent to filling prescriptions; patients do not fill their prescriptions about a 
quarter of the time, and do not take them about half of the time (AMA, 2018).  
Single marital status, lower income, and having more than 10 medications were significantly 
associated with not filling medications. Reasons included cost by 23.5% of patients. Additional reasons 
include lack of time to go to the pharmacy, medication not delivered or dispensed, and inability to afford 
the medications (Wooldridge, Schnipper, Goggins, Dittus, & Kripalani, 2016).  
Hanson, Habibi, Khamo, Abdou & Stubbings (2014) conducted a pharmacy study to examine 
whether connecting patients with a team to help address the prohibitive expense of multiple sclerosis 
drugs would improve adherence. It was in fact proven helpful, although the team concept involving 
advanced providers was an expensive concept that would be difficult to reproduce and sustain. The 
cancer center employs financial navigators, social workers, and nurse navigators who may provide a 
more sustainable coordination of care.     
Three major factors predict whether or not a patient can afford medication: 1. Insurance 
coverage, 2. overall health and 3. Income. In addition individuals who make under $50,000/year in 
income are more likely to skip doses or stop taking their medication than individuals with higher income 
(NCPA, 2013).  
Geography can be a significant hindrance for patients who live in rural areas, especially 
without reliable internet service (Heath, 2017). 
In a New York Times online journal article, Frakt (2017) cites systematic reviews and 
randomized control trials analyzing several methods to address adherence such as electronic reminders, 
pill organizers, and electronic reminder and feedback systems. The author concludes that reduced price, 
or free medications are the only consistent predictor that patients will take and refill medication as 
directed (Frakt, 2017). "For those with certain chronic conditions, extra help in affording medications can 
reduce adverse events and hospitalizations 
 - One in five adults reported taking at least four prescription drugs with 55% taking at least 
one. 35% of patients taking four or more prescription pills reported taking lower dosage or skipped doses 
(and if uninsured did not fill the prescription) compared to 25% of those taking three or fewer. Income of 
$40,000 a year or less was another predictive factor of lowering, skipping, or not filling a prescription 
(KFF, 2017).  
- 1084 adult patients at University of Pennsylvania and Pennsylvania Presbyterian hospitals 
were surveyed to discover the issues they felt caused their readmission. Among the most common 
reasons included low socioeconomic status (Medicaid or uninsured) driven barriers of obtaining and 
adhering to medication regimens (Kangovi et al., 2012).  
Irwin & Johnson (2015) cite cost or lack of insurance coverage was mentioned 26% of the 
time, and social support was a reported factor of nonadherence 32% of the time in their meta-analysis of 
qualitative research with triangulation to quantitative studies.  
Single marital status is a significant predictor of nonadherence according to one study (Greer et 
al., 2016). 
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2.  Depression, 
Distress and/or 
Anxiety 
Patients who are depressed or anxious are less likely to take their medications (AMA, 2018).  
Patient fills out PHQ-2 followed (if indicated by PHQ-2 score) by the PHQ-9. A score of 15 or higher on 
PHQ-9 indicates a moderately severe depression barring other causes such as thyroid disorder (American 
Family Physician, 2012).  
If a patient has a history of mental health disorders such as depression, anxiety, or addiction, he or she is 
less likely to adhere to their medication regimen (Millionhearts.hhs.gov, 2017). 
Greer et al. (2016) in a systematic review of adherence to oral chemotherapy agents reported that 
depression played a significant role in nonadherence, with some rates dropping to about 50% at the five-
year follow up.   
Adjuvant endocrine therapy adherence was lower in women with depressive symptoms, especially in 
younger women just starting endocrine therapy. Individuals with depression have greater non-adherence 
than patients without depressive symptoms. In this study, women with lower adherence were also found 
to have a shorter time to recurrence of their cancer, increased medical costs and worse quality of life 
(Mausbach, Schwab & Irwin, 2015).  
Long-term distress may be a predictor of non-adherence (Aikens, Trivedi, Aron, & Piette, 2015).  
 - The Oncology Nursing Society provides information gleaned from an extensive review of literature on 
medication adherence. Their resource states that treatment of depression is found to be an intervention 
that is likely to be effective (Spoelstra, & Sansoucie, 2015). 
3.  Medical 
Concerns  
The greater the number of different medications prescribed and the higher the frequency, the more likely 
that a patient will be nonadherant to their medication regimen (AMA, 2018). The relationship to the 
provider is also a predictive factor in adherence. Advertisements, news coverage and stories can have a 
negative effect and/or cause mistrust. Patients are less likely to fill their prescription if they do not trust 
the prescriber (AMA, 2018) 
"Mutually respectful collaboration with providers" is one key to improving adherence (CDC, 2017a). A 
meta-analysis of qualitative research with triangulation to quantitative research revealed a 42% frequency 
of provider relationship as a predictor of adherence in the qualitative literature. A positive relationship 
facilitates adherence while a negative relationship does the opposite (Irwin, & Johnson, 2015). 
Side effects were reason for stopping medication in 21% of self-reported reasons for nonadherence in a 
national telephone survey of 1020 adults with chronic illness and four or more medications (NCPA, 
2013). Side effects were found 40% of the time in the qualitative literature in a meta-analysis of research 
regarding nonadherence (Irwin, & Johnson, 2015). 
- A qualitative study of Turkish migrants with type 2 diabetes found that nonadherence may be impacted 
by different beliefs about medications (Peeters et al., 2015).  
- Barriers to adherence can start in the clinic or hospital setting due to medication reconciliation 
discrepancies (Balling, Erstad, & Weibel, 2015).  
-although questionnaires can be time prohibitive to administer there are some that can be effective for 
assessing nonadherence. However interviewing patients is an easy, low-cost method to assess patient's 
adherence. Although knowledge may not accurately reflect adherence, knowing that they will be asked 
about medications by their provider may encourage adherence (Lam & Fresco, 2015).  
As mentioned in the financial and social category, single marital status, lower income, and having more 
than 10 medications were significantly associated with not filling medications. Reasons included cost by 
23.5% of patients. Additional reasons include lack of time to go to the pharmacy, medication not 
delivered or dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus, 
& Kripalani, 2016). 
4. 
Behaviors/Lifesty
le
 
4. Behavioral and 
Lifestyle Barriers 
- Forgetting/Don't 
think it's 
needed/Didn't 
"agree" to take 
it/Don't like 
taking it/ too 
busy/Away from 
home/no 
established 
routine 
Forgetting was the number one self-reported reason for nonadherence in a national telephone survey 
(NCPA, 2013). However, additional research reviews of studies comparing reminder methods to control 
groups revealed that this may not be as large of an impact as previously reported (Frakt, 2017). 
Patients who express that they are tired of taking medications are showing a predicting sign that they are 
nonadherant (Millionhearts.hhs.gov, 2017). 
Frequency of forgetfulness was 38% and doubting necessity was 35% in a meta-analysis of research with 
triangulation (Irwin, & Johnson, 2015). In the same study, pill burden is mentioned with 25% frequency 
and regimen complexity 22% of the time.  
Methods to encourage patient adherence recommended by the Oncology Nursing Society include 
Reminder instruments such as calendars, pill diaries, pill boxes with compartments for time of day for 
each day of the week, electronic reminders such as alarms, timers, smart phone apps, glowing or 
electronic pill containers and medication dispensing machines (ONS, 2016).  
As mentioned in the financial and social category, single marital status, lower income, and having more 
than 10 medications were significantly associated with not filling medications. Reasons included cost by 
23.5% of patients. Additional reasons include lack of time to go to the pharmacy, medication not 
delivered or dispensed, and inability to afford the medications (Wooldridge, Schnipper, Goggins, Dittus, 
& Kripalani, 2016). 
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5.  Educational 
Barriers  
 
 
 - Predictors of nonadherence include limited English language proficiency, low literacy, don't believe in 
the benefits of medication or believe they are not necessary or even harmful (Millionhearts.hhs.gov, 
2017). 
 - Patients who do not understand the purpose, side effects, or expected time before it is effective may 
result in nonadherence. This is true in patients with chronic illness because there is often no obvious 
result so the patient may think it is not doing anything for them and stop taking it (AMA, 2018).  
 - The Oncology Nursing Society review of literature recommendations suggest in 2014 there was not 
enough information to establish education as an effective means of promoting adherence (Spoelstra, & 
Sansoucie, 2015).  However, an additional study published by the Oncology Nursing Society in 2015 
cites medication knowledge was mentioned 25% of the time in an extensive meta-analysis of qualitative 
studies triangulated with quantitative studies (Irwin, & Johnson, 2015).  
-A Joint Commission study assessing the feasibility of a three-question literacy instrument states that 
addressing health literacy is a national health priority and Standard PC.02.02.01 is cited "The hospital 
effectively communicates to patients when providing care, treatment, and services" "Health literacy is the 
degree to which individuals have the capacity to obtain, process, and understand basic health information 
and services needed to make appropriate health decisions. It is a necessary skill for successful navigation 
of the health care system, communication with providers, and management of chronic conditions. 
However, an estimated 90 million adults in the United States have low health literacy,2 which is 
associated with lower rates of preventive .care, poorer disease control, and greater mortality, as well as 
increased health care utilization and costs.3,4 (Cawthon, Mion, Willens, Roumie & Kripalani, 2014).  
Inability to read and understand directions, pill bottle labels may be due to small print, confusing medical 
terms or abbreviations as well (CDC, 2017a).  
-Patients with higher levels of education typically are correlated with better health, have had more health 
education, and can advocate better for themselves (Heath, 2017). 
Using 5th to 6th grade reading level with pictures and "teach-back" methods may help patients feel better 
prepared for discharge and to care for themselves (Parr, 2017).  
-A structured, nurse-led teaching program that included follow-up phone calls at set intervals had 
encouraging results in lung cancer patients taking an oral chemotherapy drug (Boucher, Lucca, Hooper, 
Pedulla, & Berry, 2015).  
In a systematic review of randomized control trials it was proven that group psychoeducation was 
effective in improving medication adherence in adults suffering from schizophrenia (Al-Batran, 2015).  
-A study conducted by pharmacists at MD Anderson Cancer Center in Texas showed reduced 
hospitalization when patients were contacted by a pharmacist within 30 days of discharge to have 
adherence assessed, questions answered, and any discrepancies addressed (Patel, Phuoc, Bachler & 
Atkinson, 2017).  
 - An additional pharmacist-driven study evaluated the impact of providing medications immediately 
upon discharge to patients admitted to a psychiatric unit and found that this improved adherence to the 
treatment regimen (Tomko et al., 2013). This is not feasible when a dispensing pharmacy is not readily 
available. However it may be helpful to utilize this method if available in the future. 
 - 1084 adult patients were surveyed to discover the issues they felt caused their readmission. The most 
common reasons included feeling unprepared for discharge and lack of social support. Low 
socioeconomic status (Medicaid or uninsured) were more likely to report difficulty understanding and 
executing discharge instructions (Kangovi et al., 2012). 
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APPENDIX E: Letters of Support 
 
Mrs Washburn, 
  
Thank you for your interest in this project. We are happy to grant you permission to 
work on this study and provide you any support you need. Please let me know how I can 
assist you further. 
  
Thanks, 
  
Katie Kirby, MSN, RN, OCN, CMPE, NE-BC 
Director of Practice Operations 
Lynchburg and Southside Hematology Oncology 
(434) 200-1492 
(434) 401-5167 
 
  
From: Donna Washburn  
Sent: Tuesday, March 20, 2018 11:46 AM 
To: Katie Kirby <Katie.Kirby@Centrahealth.com>; Carol Riggins <Carol.Riggins@Centrahealth.com> 
Cc: Washburn, Donna (Nursing) <djwashburn@liberty.edu> 
Subject: PERMISSION NEEDED PLEASE 
Importance: High 
  
Mrs. Carol Riggins 
Managing Director 
Centra Pearson Cancer Center 
Administrative Suite 
1701 Thomson Drive 
Lynchburg, VA 24501 
  
Mrs. Katie Kirby 
Director 
Centra Medical Oncology Clinic 
Suite 200 
1701 Thomson Drive 
Lynchburg, VA 24501 
3/20/2018 
Dear Mrs. Riggins and Mrs. Kirby, 
As a graduate student in the department at Liberty University, I am conducting an evidence-based 
practice nursing research project as part of the requirements for a Doctorate of Nursing Practice. The 
title of my study is, “Addressing barriers to medication adherence: An evidence-based screening 
instrument validation study.” The purpose of the research is to find out if an evidence-based screening 
instrument will help identify actionable barriers to successful medication adherence in patients who are 
Medicare/Medicaid eligible. If after a retrospective review of medical records, it is found that the 
screening instrument can in fact help identify actionable barriers. The screening instrument may then 
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help navigators intervene and prevent unnecessary clinic visits, emergency room visits, and 
hospitalizations, by connecting these individuals to available community resources, depending on the 
barriers identified. 
  
I am writing to request your permission to conduct the project using retrospective medical record data 
from CMS/OCM patients who have received chemotherapy in the Centra Medical Oncology Clinic within 
a year prior to IRB approval of the project. For this study, there will be no interaction with patients, no 
consent or surveys of any kind, and no prospective data collection. I will require interaction with med-
onc staff, navigator staff, and OCM staff for assistance identifying OCM patients who are eligible for 
review. This may be as simple as a printed report showing a list of potentially eligible patients for me to 
screen. I have been screened and provided with Centra student intern identification and computer 
access.   
  
Following your written permission, I will be submitting the study to the Liberty University IRB, and 
Centra IRB for approval. 
  
Thank you for considering my request. If you choose to grant permission, please provide a signed 
statement on Centra letterhead indicating your approval, or respond by e-mail 
to djwashburn@liberty.edu. 
  
Thank you 
Donna Washburn MSN, RN, CNS, ACNS-BC, AOCNS 
434-426-1278 
djwashburn@liberty.edu 
  
  
  
Regards, 
Donna 
  
Donna Washburn MSN, RN, CNS, ACNS-BC, AOCNS 
Clinical Nurse Specialist 
Director Professional Clinical Practice 
Centra Health 
Office: 434-200-3296 
  
Our Mission: Excellent Care for Life 
Our Vision: To be the Most Trusted Provider of Innovative Healthcare 
Our Nurses: Nurses have been ranked the most trusted profession 15 years in a row 
  
 
Electronic Privacy Notice. This e-mail, and any attachments, contains information that is, or may be, covered by electronic 
communications privacy laws, and is also confidential and proprietary in nature. If you are not the intended recipient, please 
be advised that you are legally prohibited from retaining, using, copying, distributing, or otherwise disclosing this 
information in any manner. Instead, please reply to the sender that you have received this communication in error, and then 
immediately delete it. Thank you in advance for your cooperation. 
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You have my permission. 
Please keep us updated. 
  
Carol Riggins, RN, MSN, GCNS-BC, OCN 
Managing Director, 
Alan B. Pearson Regional Cancer Center 
Lynchburg, VA  24501 
434-200-6601 
Carol.Riggins@centrahealth.com 
  
 
Electronic Privacy Notice. This e-mail, and any attachments, contains information that is, or may be, covered by electronic 
communications privacy laws, and is also confidential and proprietary in nature. If you are not the intended recipient, please 
be advised that you are legally prohibited from retaining, using, copying, distributing, or otherwise disclosing this 
information in any manner. Instead, please reply to the sender that you have received this communication in error, and then 
immediately delete it. Thank you in advance for your cooperation 
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APPENDIX F: Institutional Review Board Approvals 
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APPENDIX G: SPSS Coding Key and Comments 
 
SPSS Variables 
(expanded) 
Definition and Scoring System Notes 
ID Last three numbers of MRN, then subject 
number using four placeholders I.e. 0001 to 
0300 
ie: 1230001 
Gender 1 - male, 2 = female 
 
BirthYear  Year of birth 
 
CurrentMC_MA Medicare/Medicaid Patient, 1 = negative,  
2 = Positive with documented intervention,  
3 = Positive without documented 
Intervention 
Current intervention to provide insurance and 
financial counseling on initial visit prior to 
treatment  
CurrentPHQ9   
(Independent variable: 
"Current Screening") 
PHQ-9 Depression Score 15 or higher, 
 1 = negative, 2 = Positive with documented 
intervention, 3 = Positive without 
documented Intervention 
Current Scoring Tool in use, also integrated 
into W-BMA Depression, Distress, and 
Anxiety category (Part of independent 
variable for study called: "Current Screening") 
CurrentNCCNDistress 
(Independent variable: 
"Current Screening") 
NCCN Distress Score 4 or higher,  
1 = negative, 2 = Positive with documented 
intervention, 3 = Positive without 
documented Intervention 
current Scoring Tool in use, also integrated 
into W-BMA Depression, Distress, and 
Anxiety category (Part of independent 
variable for study called: "Current Screening") 
WBMA1_Fin_Soc 
(Independent variable  "W-
BMA Screen" or "W-BMA 
Instrument") 
Category 1, Financial and Social Risk,  
1 = negative, 2 = Positive with documented 
intervention, 3 = Positive without 
documented Intervention 
Washburn Barriers to Medication Adherence 
Risk Assessment Tool - Risk Factors 
associated with financial and social barriers 
(Part of independent variable usually referred 
to as: "W-BMA Screen" or "W-BMA 
Instrument") 
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WBMA2_Dep_Dis_Anx 
(Independent variable  "W-
BMA Screen" or "W-BMA 
Instrument") 
Category 2, Depression, Distress, Anxiety 
Risk, 1 = negative, 2 = Positive with 
documented intervention, 3 = Positive 
without documented Intervention 
Washburn Barriers to Medication Adherence 
Risk Assessment Tool - Risk Factors 
associated with depression, distress, and 
anxiety including PHQ-9 and NCCN Distress 
scores  (Part of independent variable usually 
referred to as: "W-BMA Screen" or "W-BMA 
Instrument") 
WBMA3_MedRelCon 
(Independent variable  "W-
BMA Screen" or "W-BMA 
Instrument") 
Category 3, Medical Related Concerns,  
1 = negative, 2 = Positive with documented 
intervention, 3 = Positive without 
documented Intervention 
Washburn Barriers to Medication Adherence 
Risk Assessment Tool - Risk Factors 
associated with medical related barriers  (Part 
of independent variable usually referred to as: 
"W-BMA Screen" or "W-BMA Instrument") 
WBMA4_Beh_Lifestyle 
(Independent variable  "W-
BMA Screen" or "W-BMA 
Instrument") 
Category 4, Behavioral and lifestyle,  
1 = negative, 2 = Positive with documented 
intervention, 3 = Positive without 
documented Intervention 
Washburn Barriers to Medication Adherence 
Risk Assessment Tool - Risk Factors 
associated with behavior and lifestyle barriers 
(Part of independent variable usually referred 
to as: "W-BMA Screen" or "W-BMA 
Instrument") 
WBMA5_Educ 
(Independent variable  "W-
BMA Screen" or "W-BMA 
Instrument") 
Category 5 Educational, 1 = negative, 
 2 = Positive with documented intervention,  
3 = Positive without documented 
Intervention 
Washburn Barriers to Medication Adherence 
Risk Assessment Tool - Risk Factors 
associated with educational barriers  (Part of 
independent variable usually referred to as: 
"W-BMA Screen" or "W-BMA Instrument") 
Diabetes_uncontolled Uncontrolled Diabetes, Defined as blood 
glucose over 140 without a formal diabetes 
diagnoses, or glucose over 180 with DMII 
diagnoses or over 130 if documented fasting. 
1 = Negative and no med, 2 = Negative and 
on associated med, 3 = Positive and no 
prescribed medication, 4 = Positive and has a 
prescribed medication 
 Uncontrolled chronic illness assessment for 
sensitivity testing. All uncontrolled illness 
grouped into one variable for primary 
statistical tests. 
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HTN_uncontrolled Uncontrolled Hypertension, Defined as BP 
greater than 140 systolic, or 90 diastolic in 
two or more visits without resolution to 
130/80 or below.   1 = Negative and no med, 
2 = Negative and on associated med,  
3 = Positive and no prescribed medication,  
4 = Positive and has a prescribed medication 
 Uncontrolled chronic illness assessment for 
sensitivity testing. All uncontrolled illness 
grouped into one variable for primary 
statistical tests. 
Renal_Imp_uncontrolled Uncontrolled Renal Illness defined as an 
abnormal GFR grade 2 or worse, or 
Creatinine Grade 2 or worse sustained over 2 
or more consecutive visits, 1 = Negative and 
no med, 2 = Negative and on associated med, 
3 = Positive and no prescribed medication,  
4 = Positive and has a prescribed medication 
(Note: this is a common adverse event 
associated with cancer treatment) 
 Uncontrolled chronic illness assessment for 
sensitivity testing. All uncontrolled illness 
grouped into one variable for primary 
statistical tests. 
Dep_Mental_uncontrolled Uncontrolled depression or mental illness, 
defined as documented in chart, 1 = Negative 
and no med, 2 = Negative and on associated 
med, 3 = Positive and no prescribed 
medication, 4 = Positive and has a prescribed 
medication 
 Uncontrolled chronic illness assessment for 
sensitivity testing. All uncontrolled illness 
grouped into one variable for primary 
statistical tests. 
COPD_uncontrolled Uncontrolled COPD, 1 = Negative and no 
med, 2 = Negative and on associated med,  
3 = Positive and no prescribed medication,  
4 = Positive and has a prescribed medication 
 Uncontrolled chronic illness assessment for 
sensitivity testing. All uncontrolled illness 
grouped into one variable for primary 
statistical tests. 
Event_Unplanned_Clinic Unplanned Outpatient Clinical Visit, 1 = 
negative or visit was unrelated or probably 
unrelated to possible medication 
nonadherence or uncontrolled illness (# 1 or 
2 negative in uncontrolled illness section),  
Event Assessment for potential correlation 
with severity of uncontrolled illness and future 
measurable financial implications of non-
adherence. 
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2 = Positive and possibly or definitely related 
to possible medication nonadherence and/or 
uncontrolled illness (# 3 or 4 positive 
responses in uncontrolled illness section) 
Event_ER Emergency Room Visit with or without 
hospitalization, 1 = negative or visit was 
unrelated or probably unrelated to possible 
medication nonadherence or uncontrolled 
illness (# 1 or 2 negative in uncontrolled 
illness section), 2 = Positive and possibly or 
definitely related to possible medication 
nonadherence and/or uncontrolled illness (# 3 
or 4 positive responses in uncontrolled illness 
section) 
Event Assessment for potential correlation 
with severity of uncontrolled illness and future 
measurable financial implications of non-
adherence. 
Event_Hospital Hospitalization (including observation), 
 1 = negative or hospitalization was unrelated 
or probably unrelated to possible medication 
nonadherence or uncontrolled illness (# 1 or 
2 negative in uncontrolled illness section),  
2 = Positive and possibly or definitely related 
to possible medication nonadherence and/or 
uncontrolled illness (# 3 or 4 positive 
responses in uncontrolled illness section) 
Event Assessment for potential correlation 
with severity of uncontrolled illness and future 
measurable financial implications of non-
adherence. 
OSS_Full_Support Oncology Support Services providing full 
support. 1 = yes, 2 = no 
Oncology Support Services providing full 
support throughout patient treatment to 
address known issues (not including "meet 
and greet" and initial pretreatment financial 
counseling) Full support focused on Navigator 
involvement, but includes Social Worker, 
Financial Support, Palliative Care.  
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NuprescribedMeds The number of prescribed meds - includes 
OTC meds recommended by provider 
Excluded: Chemotherapy treatment and 
medications used to pretreat the patient in the 
clinic prior to chemo administration. Also 
excluded: OTC medications not recommended 
by provider including allergy and cold relief 
remedies, vitamins or herbal supplements, 
pain relief medications and sleep aides 
Free Text Comments 
  
 
